<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">70235</article-id><article-id pub-id-type="doi">10.7554/eLife.70235</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group></article-categories><title-group><article-title>Identification of bipotent progenitors that give rise to myogenic and connective tissues in mouse</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-238034"><name><surname>Grimaldi</surname><given-names>Alexandre</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5978-2057</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-151409"><name><surname>Comai</surname><given-names>Glenda</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3244-3378</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-138576"><name><surname>Mella</surname><given-names>Sebastien</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8679-5718</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-61535"><name><surname>Tajbakhsh</surname><given-names>Shahragim</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1809-7202</contrib-id><email>shahragim.tajbakhsh@pasteur.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Stem Cells and Development Unit, Institut Pasteur</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>UMR CNRS 3738, Institut Pasteur</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02en5vm52</institution-id><institution>Sorbonne Universités, Complexité du Vivant, F-75005</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Cytometry and Biomarkers UTechS, Institut Pasteur</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0495fxg12</institution-id><institution>Bioinformatics and Biostatistics Hub, Institut Pasteur</institution></institution-wrap><addr-line><named-content content-type="city">Paris</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>28</day><month>02</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e70235</elocation-id><history><date date-type="received" iso-8601-date="2021-05-11"><day>11</day><month>05</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-02-25"><day>25</day><month>02</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2021-05-26"><day>26</day><month>05</month><year>2021</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2021.05.26.445757"/></event></pub-history><permissions><copyright-statement>© 2022, Grimaldi et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Grimaldi et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-70235-v3.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-70235-figures-v3.pdf"/><abstract><p>How distinct cell fates are manifested by direct lineage ancestry from bipotent progenitors, or by specification of individual cell types is a key question for understanding the emergence of tissues. The interplay between skeletal muscle progenitors and associated connective tissue cells provides a model for examining how muscle functional units are established. Most craniofacial structures originate from the vertebrate-specific neural crest cells except in the dorsal portion of the head, where they arise from cranial mesoderm. Here, using multiple lineage-tracing strategies combined with single cell RNAseq and in situ analyses, we identify bipotent progenitors expressing <italic>Myf5</italic> (an upstream regulator of myogenic fate) that give rise to both muscle and juxtaposed connective tissue. Following this bifurcation, muscle and connective tissue cells retain complementary signalling features and maintain spatial proximity. Disrupting myogenic identity shifts muscle progenitors to a connective tissue fate. The emergence of <italic>Myf5</italic>-derived connective tissue is associated with the activity of several transcription factors, including <italic>Foxp2</italic>. Interestingly, this unexpected bifurcation in cell fate was not observed in craniofacial regions that are colonised by neural crest cells. Therefore, we propose that an ancestral bi-fated program gives rise to muscle and connective tissue cells in skeletal muscles that are deprived of neural crest cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>myogenesis</kwd><kwd>connective tissue</kwd><kwd>neural crest</kwd><kwd>cranial mesoderm</kwd><kwd>scRNAseq</kwd><kwd>cranial muscles</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007393</institution-id><institution>Association Française contre les Myopathies</institution></institution-wrap></funding-source><award-id>20510</award-id><principal-award-recipient><name><surname>Grimaldi</surname><given-names>Alexandre</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002915</institution-id><institution>Fondation pour la Recherche Médicale</institution></institution-wrap></funding-source><award-id>FDT201904008277</award-id><principal-award-recipient><name><surname>Grimaldi</surname><given-names>Alexandre</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-10-LABX-73</award-id><principal-award-recipient><name><surname>Tajbakhsh</surname><given-names>Shahragim</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004794</institution-id><institution>Centre National de la Recherche Scientifique</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Comai</surname><given-names>Glenda</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-19-CE13-0008-01</award-id><principal-award-recipient><name><surname>Tajbakhsh</surname><given-names>Shahragim</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Combined lineage-tracing strategies, single-cell transcriptomic methods and in situ analyses identified mesodermal bipotent progenitors during craniofacial myogenesis that give rise to myogenic and connective tissues, thus redefining the lineage and evolutionary relationships between muscle and associated stroma.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Stromal cells that are associated with skeletal muscles play critical roles in providing structural support and molecular cues (<xref ref-type="bibr" rid="bib7">Biferali et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Kardon et al., 2003</xref>; <xref ref-type="bibr" rid="bib72">Sefton and Kardon, 2019</xref>). The majority of muscle-associated connective tissues in the head is derived from cranial neural crest cells (NCCs), an embryonic cell population that contributes to most of the structural components of the ‘new head’, a vertebrate innovation (<xref ref-type="bibr" rid="bib49">Le Douarin and Kalcheim, 1999</xref>; <xref ref-type="bibr" rid="bib30">Gans and Northcutt, 1983</xref>; <xref ref-type="bibr" rid="bib31">Grenier et al., 2009</xref>; <xref ref-type="bibr" rid="bib38">Heude et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Noden and Trainor, 2005</xref>). Recently, the extent of this contribution was redefined in muscles derived from cranial mesoderm, including extraocular (EOM), laryngeal and pharyngeal muscles (<xref ref-type="bibr" rid="bib17">Comai et al., 2020</xref>; <xref ref-type="bibr" rid="bib32">Grimaldi et al., 2015</xref>; <xref ref-type="bibr" rid="bib38">Heude et al., 2018</xref>; <xref ref-type="bibr" rid="bib46">Kuroda et al., 2021</xref>; <xref ref-type="bibr" rid="bib62">Noden and Epstein, 2010</xref>). Interestingly, these muscles contain mesenchyme that is mesoderm-derived in their dorso-medial component, whereas the remaining muscle mass is embedded in mesenchyme that is neural crest-derived. It is unclear how the coordinated emergence of myogenic and connective tissues takes place during development, and how they establish long-lasting paracrine communication.</p><p>Along the trunk axis, paraxial somitic mesoderm gives rise to skeletal muscles and associated connective tissues (<xref ref-type="bibr" rid="bib12">Burke and Nowicki, 2003</xref>). Upon signals emanating from adjacent tissues, the dermomyotome (dorsal portion of the somite) undergoes an epithelial-to-mesenchymal transition and gives rise to several cell types including all skeletal muscles of the body, vasculature, tendons and bones (<xref ref-type="bibr" rid="bib5">Ben-Yair and Kalcheim, 2008</xref>; <xref ref-type="bibr" rid="bib15">Christ et al., 2007</xref>). Similarly, cranial mesodermal progenitors give rise to these diverse cell types, yet, its unsegmented nature raises the question of how spatiotemporal control of these cellular identities is established. Moreover, cardiopharyngeal mesoderm, which constitutes the major portion of cranial mesoderm, has cardiovascular potential, which manifests in the embryo as regions of clonally related cardiac and craniofacial skeletal muscles (<xref ref-type="bibr" rid="bib24">Diogo et al., 2015</xref>; <xref ref-type="bibr" rid="bib76">Swedlund and Lescroart, 2020</xref>). This skeletal muscle/cardiac branchpoint has been the subject of intense investigation in several model organisms including ascidians, avians, and mouse (<xref ref-type="bibr" rid="bib85">Wang et al., 2019</xref>). While cardiopharyngeal mesoderm was shown to give rise to connective tissues in the mammalian pharynx, the extent of its contribution to other craniofacial muscles in general has not been fully addressed (<xref ref-type="bibr" rid="bib1">Adachi et al., 2020</xref>).</p><p>Recently, advanced pipelines integrating scRNAseq data and modern algorithms have been instrumental for identifying new lineage relationships during development (<xref ref-type="bibr" rid="bib14">Cao et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">He et al., 2020</xref>; <xref ref-type="bibr" rid="bib67">Qiu et al., 2021</xref>). Here, we employed lineage-restricted single-cell transcriptomics using multiple transgenic mouse lines combined with various computational methods, in situ labeling and loss-of-function experiments, and show that bipotent progenitors expressing the muscle determination gene <italic>Myf5</italic> give rise to both skeletal muscle and anatomically associated connective tissues. Surprisingly, this property was restricted to muscle masses lacking NCC-derived connective tissues, indicating that cranial mesoderm acts as a source of connective tissues in the absence of neural crest cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Myogenic and non-myogenic mesodermal populations coexist within distinct head lineages</title><p>Somitic (<italic>Pax3</italic>-dependent) and cranial (<italic>Tbx1/Pitx2-dependent</italic>) mesoderm give rise to diverse cell types including those of the musculoskeletal system (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We first set out to explore the emergence of skeletal muscles and other associated mesodermal tissue within these programs. To that end, we employed a broad anterior mesoderm lineage-tracing strategy using the <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> line as it labels cranial-derived mesoderm and the anterior somites (<xref ref-type="bibr" rid="bib38">Heude et al., 2018</xref>). At E10.5, when craniofacial skeletal muscles start to be specified, the upper third (anterior to forelimb) of the embryos was dissected, live GFP+ cells were isolated by FACS, and processed for scRNAseq analysis (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A-C</xref>). After removal of doublets and lower quality cells (see Materials and methods), a large portion of the cells obtained by <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> lineage tracing segregated as individual clusters expressing markers of adipogenic, chondrogenic, sclerotomal, endothelial, and cardiovascular lineages as well as the foregut and primitive lung mesenchyme (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A-B</xref>). <italic>Pax3</italic>, <italic>Pitx2</italic>, <italic>Tbx1</italic>, <italic>Myf5,</italic> and <italic>Myod</italic> expression were used to identify clusters containing the cranial myogenic progenitors, annotated as ‘Cardiopharyngeal mesoderm’ and ‘Anterior somite’ (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>scRNAseq reveals non-myogenic populations of cranial mesoderm lineages.</title><p>(<bold>A</bold>) Scheme of connective tissue origin in the head and known mesodermal upstream regulators. E: Eye, 1–4: Pharyngeal arches 1–4. (<bold>B–F</bold>) scRNAseq analysis on <italic>Mesp1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> embryos at E10.5 (2 datasets of 2 embryos were aggregated to generate this data, see methods). (<bold>B</bold>) UMAP of <italic>Mesp1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E10.5 scRNAseq with main cell types highlighted. The clusters ‘Anterior somite’ and ‘Cardiopharyngeal mesoderm’ were subsetted for further analysis below. (<bold>C</bold>) UMAP expression plots of <italic>Pitx2</italic> (EOM), <italic>Tbx1</italic> (cranial mesoderm except EOM) and <italic>Pax3</italic> (somitic mesoderm), indicating the clusters of progenitors that were selected. (<bold>D</bold>) UMAP of progenitor subset annotated as myogenic and non-myogenic based on expression patterns found in E and F. (<bold>E</bold>) UMAP expression plots of <italic>Pitx2</italic>, <italic>Tbx1</italic> and <italic>Pax3</italic> in the <italic>Mesp1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E10.5 subset. (<bold>F</bold>) Heatmap of top 20 markers of myogenic versus non-myogenic clusters <italic>Mesp1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E10.5 subset. <italic>Pdgfra/Pdgfa</italic> genes are highlighted.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig1-v3.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>FACS strategy and preprocessing metrics of the <italic>Mesp1</italic>-derived E10.5 dataset.</title><p>(<bold>A</bold>) Gating strategy used to isolate by FACS <italic>Mesp1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> cells. The FITC channel was used to identify GFP+ cells. The AmCyan channel was used to identify the Calcein Blue+ live cells. The PE-Texas Red channel was used to discard mTomato+ cells and Propidium Iodide+ cells. The percentage of cells captured by each gate is displayed on each plot. (<bold>B</bold>) Violin plots of gene count, UMI count and mitochondrial fraction for overall dataset. (<bold>C</bold>) Violin plots of gene count and UMI count by cluster (n = 2 pooled datasets).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig1-figsupp1-v3.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Genetic markers defining anterior mesodermal tissues.</title><p>(<bold>A</bold>) <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> E10.5 UMAP expression plots of markers of various mesodermal lineages. (<bold>B</bold>) Heatmap of top 5 markers of each cluster of <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> E10.5. (<bold>C</bold>) UMAP expression plot of the <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> E10.5 subset. <italic>En2</italic>: marker of pharyngeal arch 1 (<xref ref-type="bibr" rid="bib44">Knight et al., 2008</xref>), <italic>En1</italic>: marker of epaxial somitic progenitors (<xref ref-type="bibr" rid="bib74">Spörle, 2001</xref>), <italic>Lbx1</italic>: marker of tongue progenitors (<xref ref-type="bibr" rid="bib34">Gross et al., 2000</xref>), <italic>Isl1</italic>: marker of cardiopharyngeal mesoderm of pharyngeal arch 2–6 (<xref ref-type="bibr" rid="bib60">Nathan et al., 2008</xref>), <italic>Shox2</italic>: marker of caudal cardiopharyngeal mesoderm (<xref ref-type="bibr" rid="bib86">Wang et al., 2020</xref>), <italic>Pitx2</italic>: marker of the extraocular region (<xref ref-type="bibr" rid="bib91">Zacharias et al., 2011</xref>) (n = 2 pooled datasets).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig1-figsupp2-v3.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Complementary Pdgf signaling defines myogenic and non-myogenic mesodermal cells.</title><p>(<bold>A</bold>) Pearson correlation plot of myogenic (<italic>Pdgfa, Myf5, Myod1, Myog, Acta2</italic>) and non-myogenic (<italic>Pdgfra, Prrx1, Meis1, Twist1, Osr1, Col1a1</italic>) genes in the <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> E10.5 subset. The size of the dots is inversely proportional to their p-value. A cross indicates a p-value &gt; 0.05. The color of the dots indicates the strength of the positive (blue) or negative (red) correlation. (<bold>B</bold>) Expression patterns of <italic>Myf5, Myod, Myog, Pdgfa, Pdgfra</italic>, and <italic>Col1a1</italic> in the <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> E10.5 subset dataset. Note that Myf5+ cells were overwhelmingly Pdgfra- and Myf5+/Pdgfra+ cells represent 8% of all cells (i.e. expressing at least one transcript of both genes). Pdgfra+ cells represent 40% of all cells (n = 2 pooled datasets).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig1-figsupp3-v3.tif"/></fig></fig-group><p>After subsetting these clusters (‘Cardiopharyngeal mesoderm’ and ‘Anterior somite’), a few subclusters clearly separated based on their origin and anatomical location (<xref ref-type="fig" rid="fig1">Figure 1D–E</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2C</xref>). Surprisingly, about half of the supposedly myogenic cells exhibited a connective tissue signature, including a strong bias toward <italic>Prrx1</italic>, a marker of lateral plate mesoderm (<xref ref-type="bibr" rid="bib25">Durland et al., 2008</xref>), <italic>Col1a1</italic>, a major extracellular matrix component of connective tissue cells (<xref ref-type="bibr" rid="bib22">De Micheli et al., 2020</xref>), and <italic>Twist1</italic>, a key determinant for the mesenchymal properties of cranial mesoderm (<xref ref-type="bibr" rid="bib8">Bildsoe et al., 2016</xref>; <xref ref-type="fig" rid="fig1">Figure 1F</xref>). Furthermore, the expression of <italic>Pdgfra</italic>, a well-defined marker of stromal cells (<xref ref-type="bibr" rid="bib27">Farahani and Xaymardan, 2015</xref>), was robustly anticorrelated with the expression of its ligand <italic>Pdgfa</italic> and associated with non-myogenic genes. Conversely, <italic>Pdgfa,</italic> was correlated with a myogenic cell state (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A-B</xref>). Of note, myogenic <italic>Pdgfa</italic> expression was shown to promote adjacent sclerotomal cells to adopt a rib cartilage fate (<xref ref-type="bibr" rid="bib78">Tallquist et al., 2000</xref>). Therefore, this analysis identified anatomically distinct muscle and closely associated connective tissue progenitors and highlights a potential PDGFR-mediated crosstalk between these 2 cells types.</p></sec><sec id="s2-2"><title>Transcriptional trajectories reveal a myogenic to non-myogenic cell state transition</title><p>To understand the lineage relationship between myogenic and non-myogenic cells, we exploited the unspliced and spliced variants of our scRNAseq data, and computed the RNA velocity in each cell, using a recently described tool (<xref ref-type="bibr" rid="bib6">Bergen et al., 2020</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). RNA velocity interrogates the relative abundance of unspliced and spliced gene variants, which depends on the rates of transcription, degradation, and splicing to infer directional trajectories (<xref ref-type="bibr" rid="bib6">Bergen et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">La Manno et al., 2018</xref>). The cell cycle status constitutes a potential bias in scRNAseq data, especially when heterogeneous populations undergo cellular expansion, commitment and differentiation (<xref ref-type="bibr" rid="bib56">McDavid et al., 2016</xref>). To eliminate this potential bias, cell cycle genes were consistently regressed out during preprocessing and directional trajectories were overlaid with cell cycle phase visualization for comparisons (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>, Materials and methods). Notably, RNA velocity-inferred trajectories suggested that Myf5+ cells from the myogenic compartment contributed to non-myogenic cells (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). These calculations were based on gene- and cluster-specific dynamics, which yield higher accuracy than the initially described RNA velocity method, while providing quantitative metrics for quality control (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B-D</xref> and Materials and methods).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Transcriptomic dynamics reveal a myogenic to non-myogenic transition in anterior somite progenitors.</title><p>(<bold>A</bold>) Velocity UMAP plots of <italic>Mesp1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> embryos at E10.5 displaying myogenic and non-myogenic clusters. Arrows represent the lineage progression based on RNA velocity (relative abundance of unspliced and spliced transcripts). (<bold>B</bold>) Heatmap of driver genes accounting for anterior somite velocity, highlighting <italic>Pdgfra</italic>. Driver genes are genes that are transcriptomically active in a given cluster. (<bold>C</bold>) Phase portraits of few selected driver genes in the anterior somites: <italic>Foxp1, Meox2, Meis1, Twist2, Fap, Pdgfra, Prrx1,</italic> and <italic>Pcolce</italic>. Y-axis represents the amount of unspliced transcript per cell; X-axis represents the number of spliced transcripts per cell. A high fraction of unspliced variants indicates an active transcription of the locus, while the inverse indicates inactive/repressed transcription. Dynamics of transcription were inferred at a gene- and cluster-specific level (see Methods). (<bold>D</bold>) Phase portraits, RNA velocity and expression plots of <italic>Pdgfa</italic> and <italic>Pdgfra</italic> showing splicing dynamics of these two genes. (<bold>E</bold>) Working model of myogenic and non-myogenic fate decisions from a common bipotent progenitor in anterior somites.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cell cycle phases and RNA velocity metrics of the <italic>Mesp1</italic>-derived E10.5 dataset.</title><p>(<bold>A</bold>) UMAP of <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> E10.5 subset with overlaid velocity and cell cycle phase. (<bold>B–D</bold>) Quality control metrics of scvelo, including velocity length, velocity confidence and spliced/unspliced abundance in the overall dataset and by cluster (n = 2 pooled datasets).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig2-figsupp1-v3.tif"/></fig></fig-group><p>Another powerful feature of this method is the ability to infer ‘driver genes’ that are responsible for most of the calculated RNA velocity, hence actively transcribed, or repressed (<xref ref-type="bibr" rid="bib6">Bergen et al., 2020</xref>). Therefore, these genes can identify transitory states underlying cell fate decisions. We used this approach to uncover the driver genes that were responsible for the velocity found in anterior somites, as these cells displayed the most consistent directionality, and appeared to be independent of cell cycle (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Top transcribed driver genes included <italic>Foxp1 (</italic><xref ref-type="bibr" rid="bib73">Shao and Wei, 2018</xref><italic>), Meox2 (</italic><xref ref-type="bibr" rid="bib63">Noizet et al., 2016</xref><italic>), Meis1 (</italic><xref ref-type="bibr" rid="bib52">López-Delgado et al., 2020</xref><italic>), Twist2 (</italic><xref ref-type="bibr" rid="bib29">Franco et al., 2009</xref><italic>), Fap (</italic><xref ref-type="bibr" rid="bib66">Puré and Blomberg, 2018</xref><italic>), Pdgfra (</italic><xref ref-type="bibr" rid="bib78">Tallquist et al., 2000</xref><italic>), Prrx1 (</italic><xref ref-type="bibr" rid="bib50">Leavitt et al., 2020</xref>), and <italic>Pcolce (</italic><xref ref-type="bibr" rid="bib8">Bildsoe et al., 2016</xref>; <xref ref-type="fig" rid="fig2">Figure 2C</xref>), which are associated with fibrosis and connective tissue development. Interestingly, we noted that <italic>Pdgfra</italic> appeared as a driver gene and was activated along this inferred trajectory, whereas <italic>Pdgfa</italic> expression decreased rapidly (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Taken together, RNA velocity analysis for anterior somite mesodermal progenitors showed that Myf5+/Pdgfa+ cells shifted toward a non-myogenic fate, which includes the downregulation of <italic>Myf5</italic> and <italic>Pdgfa</italic> and the activation of <italic>Pdgfra</italic> expression (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Driver genes underlying cell fate decisions in each dataset.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">E10.5 Anterior somites</th><th align="left" valign="bottom">E11.5 EOM Myogenic</th><th align="left" valign="bottom">E11.5 EOM Non-myogenic</th><th align="left" valign="bottom">E12.5 Non-myogenic</th><th align="left" valign="bottom">E14.5 Non-myogenic</th></tr></thead><tbody><tr><td align="left" valign="bottom">Tshz2</td><td align="left" valign="bottom">Ccdc141</td><td align="left" valign="bottom">Zfpm2</td><td align="left" valign="bottom">Mgat4c</td><td align="left" valign="bottom">Dnm1</td></tr><tr><td align="left" valign="bottom">Eya1</td><td align="left" valign="bottom">Mcm6</td><td align="left" valign="bottom">Plxna4</td><td align="left" valign="bottom">Cenpv</td><td align="left" valign="bottom">Pid1</td></tr><tr><td align="left" valign="bottom">C1qtnf3</td><td align="left" valign="bottom">Dync1i1</td><td align="left" valign="bottom">Col23a1</td><td align="left" valign="bottom">C130073E24Rik</td><td align="left" valign="bottom">Nrp2</td></tr><tr><td align="left" valign="bottom">Meis2</td><td align="left" valign="bottom">Tpm2</td><td align="left" valign="bottom">Edil3</td><td align="left" valign="bottom">Tbx3os1</td><td align="left" valign="bottom">Ntrk3</td></tr><tr><td align="left" valign="bottom">Limch1</td><td align="left" valign="bottom">Celf2</td><td align="left" valign="bottom">Map2</td><td align="left" valign="bottom">E330013P04Rik</td><td align="left" valign="bottom">Tmem132c</td></tr><tr><td align="left" valign="bottom">Moxd1</td><td align="left" valign="bottom">Sox6</td><td align="left" valign="bottom">Rora</td><td align="left" valign="bottom">Stk26</td><td align="left" valign="bottom">Egflam</td></tr><tr><td align="left" valign="bottom">Epha4</td><td align="left" valign="bottom">Tnc</td><td align="left" valign="bottom">Sema5a</td><td align="left" valign="bottom">Edil3</td><td align="left" valign="bottom">Gpr153</td></tr><tr><td align="left" valign="bottom">Pitx2</td><td align="left" valign="bottom">Magi3</td><td align="left" valign="bottom">Colec12</td><td align="left" valign="bottom">Fdft1</td><td align="left" valign="bottom">Efemp1</td></tr><tr><td align="left" valign="bottom">Parm1</td><td align="left" valign="bottom">Sh3glb1</td><td align="left" valign="bottom">Smoc1</td><td align="left" valign="bottom">Lima1</td><td align="left" valign="bottom">Adamts2</td></tr><tr><td align="left" valign="bottom">Hpse2</td><td align="left" valign="bottom">Parm1</td><td align="left" valign="bottom">Ptprt</td><td align="left" valign="bottom">Trim59</td><td align="left" valign="bottom">Brinp1</td></tr><tr><td align="left" valign="bottom">Lrrn1</td><td align="left" valign="bottom">Ephb1</td><td align="left" valign="bottom">Ror1</td><td align="left" valign="bottom">Meg3</td><td align="left" valign="bottom">Vegfc</td></tr><tr><td align="left" valign="bottom">Dmrt2</td><td align="left" valign="bottom">Bmpr1b</td><td align="left" valign="bottom">Dock5</td><td align="left" valign="bottom">Gins3</td><td align="left" valign="bottom">Twist2</td></tr><tr><td align="left" valign="bottom">Myl3</td><td align="left" valign="bottom">Hells</td><td align="left" valign="bottom">Map1b</td><td align="left" valign="bottom">Tpm2</td><td align="left" valign="bottom">Itgb5</td></tr><tr><td align="left" valign="bottom">Fap</td><td align="left" valign="bottom">Pdgfc</td><td align="left" valign="bottom">Fn1</td><td align="left" valign="bottom">Cdh6</td><td align="left" valign="bottom">Gria1</td></tr><tr><td align="left" valign="bottom">Hs6st2</td><td align="left" valign="bottom">Ptprd</td><td align="left" valign="bottom">Limch1</td><td align="left" valign="bottom">Csmd3</td><td align="left" valign="bottom">Sned1</td></tr><tr><td align="left" valign="bottom">Ddr2</td><td align="left" valign="bottom">Cnr1</td><td align="left" valign="bottom">Tenm4</td><td align="left" valign="bottom">Tceal5</td><td align="left" valign="bottom">Sorcs3</td></tr><tr><td align="left" valign="bottom">Cald1</td><td align="left" valign="bottom">Sema3d</td><td align="left" valign="bottom">Rbms3</td><td align="left" valign="bottom">Pclaf</td><td align="left" valign="bottom">Ebf2</td></tr><tr><td align="left" valign="bottom">Prrx1</td><td align="left" valign="bottom">Clcn5</td><td align="left" valign="bottom">Srgap3</td><td align="left" valign="bottom">Tspan9</td><td align="left" valign="bottom">Fam19a1</td></tr><tr><td align="left" valign="bottom">Magi3</td><td align="left" valign="bottom">Chd7</td><td align="left" valign="bottom">Tmem132c</td><td align="left" valign="bottom">Eps8</td><td align="left" valign="bottom">Trabd2b</td></tr><tr><td align="left" valign="bottom">Ntn1</td><td align="left" valign="bottom">Col25a1</td><td align="left" valign="bottom">Sdc2</td><td align="left" valign="bottom">Lmna</td><td align="left" valign="bottom">Plxdc2</td></tr><tr><td align="left" valign="bottom">Zfhx3</td><td align="left" valign="bottom">Reep1</td><td align="left" valign="bottom">Add3</td><td align="left" valign="bottom">Dmrt2</td><td align="left" valign="bottom">Sh3gl3</td></tr><tr><td align="left" valign="bottom">Meis1</td><td align="left" valign="bottom">Ctnnal1</td><td align="left" valign="bottom">Pdgfra</td><td align="left" valign="bottom">Cpeb4</td><td align="left" valign="bottom">Luzp2</td></tr><tr><td align="left" valign="bottom">Tnni1</td><td align="left" valign="bottom">Tpm1</td><td align="left" valign="bottom">Gmds</td><td align="left" valign="bottom">Hpgd</td><td align="left" valign="bottom">Pdzd2</td></tr><tr><td align="left" valign="bottom">Crym</td><td align="left" valign="bottom">Zim1</td><td align="left" valign="bottom">St6galnac3</td><td align="left" valign="bottom">Rcsd1</td><td align="left" valign="bottom">Sema3e</td></tr><tr><td align="left" valign="bottom">Ebf1</td><td align="left" valign="bottom">Lmx1a</td><td align="left" valign="bottom">Epb41l3</td><td align="left" valign="bottom">Pdgfra</td><td align="left" valign="bottom">Rims1</td></tr><tr><td align="left" valign="bottom">Nr2f1</td><td align="left" valign="bottom">Neb</td><td align="left" valign="bottom">Pde3a</td><td align="left" valign="bottom">Plac1</td><td align="left" valign="bottom">Epha3</td></tr><tr><td align="left" valign="bottom">Ntng1</td><td align="left" valign="bottom">Atad2</td><td align="left" valign="bottom">Tox</td><td align="left" valign="bottom">Palmd</td><td align="left" valign="bottom">Cyp7b1</td></tr><tr><td align="left" valign="bottom">Pgm5</td><td align="left" valign="bottom">Dapk2</td><td align="left" valign="bottom">Smarca2</td><td align="left" valign="bottom">Gucy1a1</td><td align="left" valign="bottom">Gem</td></tr><tr><td align="left" valign="bottom">Cdh6</td><td align="left" valign="bottom">Prox1</td><td align="left" valign="bottom">Ctdspl</td><td align="left" valign="bottom">Wif1</td><td align="left" valign="bottom">Ldb2</td></tr><tr><td align="left" valign="bottom">Foxp1</td><td align="left" valign="bottom">Lsamp</td><td align="left" valign="bottom">Magi2</td><td align="left" valign="bottom">Naalad2</td><td align="left" valign="bottom">Scube1</td></tr><tr><td align="left" valign="bottom">Celf2</td><td align="left" valign="bottom">Ttn</td><td align="left" valign="bottom">Dpysl3</td><td align="left" valign="bottom">Smoc2</td><td align="left" valign="bottom">Pdgfra</td></tr><tr><td align="left" valign="bottom">Tbx1</td><td align="left" valign="bottom">Pls3</td><td align="left" valign="bottom">Fgfr2</td><td align="left" valign="bottom">Rassf4</td><td align="left" valign="bottom">Pde1a</td></tr><tr><td align="left" valign="bottom">Bdnf</td><td align="left" valign="bottom">Slf2</td><td align="left" valign="bottom">Ldb2</td><td align="left" valign="bottom">Pttg1</td><td align="left" valign="bottom">Nde1</td></tr><tr><td align="left" valign="bottom">Colec12</td><td align="left" valign="bottom">Vat1l</td><td align="left" valign="bottom">Igf1</td><td align="left" valign="bottom">Josd2</td><td align="left" valign="bottom">Enpp2</td></tr><tr><td align="left" valign="bottom">Eya4</td><td align="left" valign="bottom">E2f1</td><td align="left" valign="bottom">Elk3</td><td align="left" valign="bottom">Plxna4</td><td align="left" valign="bottom">Fam107b</td></tr><tr><td align="left" valign="bottom">Sobp</td><td align="left" valign="bottom">Epb41l2</td><td align="left" valign="bottom">Zmiz1</td><td align="left" valign="bottom">Eya2</td><td align="left" valign="bottom">Stxbp6</td></tr><tr><td align="left" valign="bottom">Peg3</td><td align="left" valign="bottom">Gm28653</td><td align="left" valign="bottom">Dlc1</td><td align="left" valign="bottom">Nrsn1</td><td align="left" valign="bottom">Rerg</td></tr><tr><td align="left" valign="bottom">Pdgfra</td><td align="left" valign="bottom">Lrrn1</td><td align="left" valign="bottom">Nhs</td><td align="left" valign="bottom">Fign</td><td align="left" valign="bottom">Prex2</td></tr><tr><td align="left" valign="bottom">Nrk</td><td align="left" valign="bottom">Mef2c</td><td align="left" valign="bottom">Cdkn1c</td><td align="left" valign="bottom">Inppl1</td><td align="left" valign="bottom">Man1a</td></tr><tr><td align="left" valign="bottom">Ptn</td><td align="left" valign="bottom">St8sia2</td><td align="left" valign="bottom">Plpp3</td><td align="left" valign="bottom">Rnf152</td><td align="left" valign="bottom">Tmem45a</td></tr><tr><td align="left" valign="bottom">Daam1</td><td align="left" valign="bottom">Tshz1</td><td align="left" valign="bottom">Ebf1</td><td align="left" valign="bottom">Lasp1</td><td align="left" valign="bottom">Sh3bp4</td></tr><tr><td align="left" valign="bottom">Dlk1</td><td align="left" valign="bottom">Wee1</td><td align="left" valign="bottom">Sorbs2</td><td align="left" valign="bottom">Mrln</td><td align="left" valign="bottom">Mcc</td></tr><tr><td align="left" valign="bottom">Unc5c</td><td align="left" valign="bottom">Slc24a3</td><td align="left" valign="bottom">Baz1a</td><td align="left" valign="bottom">Cdt1</td><td align="left" valign="bottom">Ncald</td></tr><tr><td align="left" valign="bottom">Lpar1</td><td align="left" valign="bottom">Ncoa1</td><td align="left" valign="bottom">Fat4</td><td align="left" valign="bottom">Notch3</td><td align="left" valign="bottom">Kdelr2</td></tr><tr><td align="left" valign="bottom">Syne2</td><td align="left" valign="bottom">Dek</td><td align="left" valign="bottom">Golgb1</td><td align="left" valign="bottom">Pax3</td><td align="left" valign="bottom">Pcdh19</td></tr><tr><td align="left" valign="bottom">Nkd2</td><td align="left" valign="bottom">Kdm5b</td><td align="left" valign="bottom">Hpse2</td><td align="left" valign="bottom">Egfr</td><td align="left" valign="bottom">Gas7</td></tr><tr><td align="left" valign="bottom">Brinp1</td><td align="left" valign="bottom">Unc13c</td><td align="left" valign="bottom">Samd4</td><td align="left" valign="bottom">Dbf4</td><td align="left" valign="bottom">Cpt1c</td></tr><tr><td align="left" valign="bottom">Zfhx4</td><td align="left" valign="bottom">Ddr1</td><td align="left" valign="bottom">Itga9</td><td align="left" valign="bottom">Bcr</td><td align="left" valign="bottom">Adam22</td></tr><tr><td align="left" valign="bottom">Nnat</td><td align="left" valign="bottom">Pip4k2a</td><td align="left" valign="bottom">Magi1</td><td align="left" valign="bottom">Mllt3</td><td align="left" valign="bottom">Itgb8</td></tr><tr><td align="left" valign="bottom">Gxylt2</td><td align="left" valign="bottom">Fndc3c1</td><td align="left" valign="bottom">Pcdh9</td><td align="left" valign="bottom">Nectin1</td><td align="left" valign="bottom">Dchs2</td></tr><tr><td align="left" valign="bottom">Clmp</td><td align="left" valign="bottom">Rbm24</td><td align="left" valign="bottom">Tgfbr2</td><td align="left" valign="bottom">Grin3a</td><td align="left" valign="bottom">Cep350</td></tr><tr><td align="left" valign="bottom">Ror2</td><td align="left" valign="bottom">Rreb1</td><td align="left" valign="bottom">Ntf3</td><td align="left" valign="bottom">Cbfa2t3</td><td align="left" valign="bottom">Oat</td></tr><tr><td align="left" valign="bottom">Nfia</td><td align="left" valign="bottom">Rragd</td><td align="left" valign="bottom">Col11a1</td><td align="left" valign="bottom">Cdh2</td><td align="left" valign="bottom">Rab30</td></tr><tr><td align="left" valign="bottom">Ebf2</td><td align="left" valign="bottom">Acsl3</td><td align="left" valign="bottom">Runx1t1</td><td align="left" valign="bottom">Anln</td><td align="left" valign="bottom">Aff2</td></tr><tr><td align="left" valign="bottom">Ednra</td><td align="left" valign="bottom">Acvr2a</td><td align="left" valign="bottom">Tnrc18</td><td align="left" valign="bottom">Ccdc6</td><td align="left" valign="bottom">Gna14</td></tr><tr><td align="left" valign="bottom">Fli1</td><td align="left" valign="bottom">Zeb1</td><td align="left" valign="bottom">Crym</td><td align="left" valign="bottom">Mcu</td><td align="left" valign="bottom">Slc29a1</td></tr><tr><td align="left" valign="bottom">Tspan12</td><td align="left" valign="bottom">Rgma</td><td align="left" valign="bottom">Fap</td><td align="left" valign="bottom">Fnip2</td><td align="left" valign="bottom">Pls3</td></tr><tr><td align="left" valign="bottom">Ttc28</td><td align="left" valign="bottom">Arpp21</td><td align="left" valign="bottom">Ppp1r1a</td><td align="left" valign="bottom">Kcnk13</td><td align="left" valign="bottom">Traf3ip1</td></tr><tr><td align="left" valign="bottom">Nfib</td><td align="left" valign="bottom">Lef1</td><td align="left" valign="bottom">Tes</td><td align="left" valign="bottom">Sned1</td><td align="left" valign="bottom">Rcsd1</td></tr><tr><td align="left" valign="bottom">Ccdc88c</td><td align="left" valign="bottom">Nr2f2</td><td align="left" valign="bottom">Bicc1</td><td align="left" valign="bottom">Nde1</td><td align="left" valign="bottom">Lgr4</td></tr><tr><td align="left" valign="bottom">Col13a1</td><td align="left" valign="bottom">Foxo1</td><td align="left" valign="bottom">Il1rapl1</td><td align="left" valign="bottom">Hipk3</td><td align="left" valign="bottom">Zfp9</td></tr><tr><td align="char" char="." valign="bottom">2700069I18Rik</td><td align="left" valign="bottom">Pdzrn4</td><td align="left" valign="bottom">Alcam</td><td align="left" valign="bottom">Arhgap11a</td><td align="left" valign="bottom">Hs3st5</td></tr><tr><td align="left" valign="bottom">Pcolce</td><td align="left" valign="bottom">Hmga2</td><td align="char" char="." valign="bottom">2700069I18Rik</td><td align="left" valign="bottom">Fam8a1</td><td align="left" valign="bottom">Aspn</td></tr><tr><td align="left" valign="bottom">Scn3a</td><td align="left" valign="bottom">Lurap1l</td><td align="left" valign="bottom">Dab2</td><td align="left" valign="bottom">Kif21a</td><td align="left" valign="bottom">Nrxn1</td></tr><tr><td align="left" valign="bottom">Acvr2a</td><td align="left" valign="bottom">Pkig</td><td align="left" valign="bottom">Cntln</td><td align="left" valign="bottom">Mtss1</td><td align="left" valign="bottom">Rrm1</td></tr><tr><td align="left" valign="bottom">Auts2</td><td align="left" valign="bottom">Ncl</td><td align="left" valign="bottom">Clmn</td><td align="left" valign="bottom">Abcd2</td><td align="left" valign="bottom">Igfbp7</td></tr><tr><td align="left" valign="bottom">Col3a1</td><td align="left" valign="bottom">CT025619.1</td><td align="left" valign="bottom">Rbms1</td><td align="left" valign="bottom">Irx5</td><td align="left" valign="bottom">Slc35f3</td></tr><tr><td align="left" valign="bottom">Gap43</td><td align="left" valign="bottom">Erbb4</td><td align="left" valign="bottom">Tmem2</td><td align="left" valign="bottom">Pacs2</td><td align="left" valign="bottom">Kif15</td></tr><tr><td align="left" valign="bottom">Mrln</td><td align="left" valign="bottom">Cdk14</td><td align="left" valign="bottom">Cdh6</td><td align="left" valign="bottom">Nab1</td><td align="left" valign="bottom">Slc1a3</td></tr><tr><td align="left" valign="bottom">Pax3</td><td align="left" valign="bottom">Kif21a</td><td align="left" valign="bottom">Lypd6</td><td align="left" valign="bottom">Ccnd2</td><td align="left" valign="bottom">Bmp6</td></tr><tr><td align="left" valign="bottom">Sim1</td><td align="left" valign="bottom">Zfp704</td><td align="left" valign="bottom">Mmp2</td><td align="left" valign="bottom">Bok</td><td align="left" valign="bottom">Dkk2</td></tr><tr><td align="left" valign="bottom">Epb41l2</td><td align="left" valign="bottom">Nasp</td><td align="left" valign="bottom">Kif5c</td><td align="left" valign="bottom">Dok5</td><td align="left" valign="bottom">Tspan9</td></tr><tr><td align="left" valign="bottom">Ppp3ca</td><td align="left" valign="bottom">Plekha5</td><td align="left" valign="bottom">Cadm2</td><td align="left" valign="bottom">Ncapg</td><td align="left" valign="bottom">Ets1</td></tr><tr><td align="left" valign="bottom">Tnfaip6</td><td align="left" valign="bottom">Cap2</td><td align="left" valign="bottom">Prkg2</td><td align="left" valign="bottom">Rfx8</td><td align="left" valign="bottom">Gria3</td></tr><tr><td align="left" valign="bottom">Tmem132c</td><td align="left" valign="bottom">Snca</td><td align="left" valign="bottom">Cped1</td><td align="left" valign="bottom">Fhod3</td><td align="left" valign="bottom">Sox8</td></tr><tr><td align="left" valign="bottom">Tmem2</td><td align="left" valign="bottom">Epha4</td><td align="left" valign="bottom">Dtl</td><td align="left" valign="bottom">Tk1</td><td align="left" valign="bottom">Melk</td></tr><tr><td align="left" valign="bottom">Epb41l3</td><td align="left" valign="bottom">Atad5</td><td align="left" valign="bottom">Ror2</td><td align="left" valign="bottom">Asf1b</td><td align="left" valign="bottom">Ntm</td></tr><tr><td align="left" valign="bottom">Crybg3</td><td align="left" valign="bottom">Cntn3</td><td align="left" valign="bottom">Utrn</td><td align="left" valign="bottom">Tek</td><td align="left" valign="bottom">Synpo2l</td></tr><tr><td align="left" valign="bottom">Nrxn1</td><td align="left" valign="bottom">Cacna2d1</td><td align="left" valign="bottom">Foxp1</td><td align="left" valign="bottom">Arfgef3</td><td align="left" valign="bottom">Hlf</td></tr><tr><td align="left" valign="bottom">Farp1</td><td align="left" valign="bottom">Pak3</td><td align="left" valign="bottom">L3mbtl3</td><td align="left" valign="bottom">Rnf182</td><td align="left" valign="bottom">Adamts5</td></tr><tr><td align="left" valign="bottom">Sulf1</td><td align="left" valign="bottom">Megf10</td><td align="left" valign="bottom">Cdh23</td><td align="left" valign="bottom">Kif14</td><td align="left" valign="bottom">Plcb4</td></tr><tr><td align="left" valign="bottom">Tmtc2</td><td align="left" valign="bottom">Tnnt1</td><td align="left" valign="bottom">Negr1</td><td align="char" char="." valign="bottom">1810041L15Rik</td><td align="left" valign="bottom">Cdc25b</td></tr><tr><td align="left" valign="bottom">Pde4dip</td><td align="left" valign="bottom">Acta2</td><td align="left" valign="bottom">Hmcn1</td><td align="left" valign="bottom">Rrm2</td><td align="left" valign="bottom">Mgat4a</td></tr><tr><td align="left" valign="bottom">Phldb2</td><td align="left" valign="bottom">Barx2</td><td align="left" valign="bottom">Col26a1</td><td align="left" valign="bottom">Fgf5</td><td align="left" valign="bottom">Mdfic</td></tr><tr><td align="left" valign="bottom">Plpp3</td><td align="left" valign="bottom">Mrln</td><td align="left" valign="bottom">Fbn2</td><td align="left" valign="bottom">Barx2</td><td align="left" valign="bottom">Trpc5</td></tr><tr><td align="left" valign="bottom">Ybx3</td><td align="left" valign="bottom">Pgm5</td><td align="left" valign="bottom">Ankrd12</td><td align="left" valign="bottom">Fli1</td><td align="left" valign="bottom">Kif4</td></tr><tr><td align="left" valign="bottom">Ppm1l</td><td align="left" valign="bottom">Fmr1</td><td align="left" valign="bottom">Lhfp</td><td align="left" valign="bottom">Jph2</td><td align="left" valign="bottom">Plce1</td></tr><tr><td align="left" valign="bottom">Twist2</td><td align="left" valign="bottom">Smc4</td><td align="left" valign="bottom">Hs3st3b1</td><td align="left" valign="bottom">Dtx4</td><td align="left" valign="bottom">Il17rd</td></tr><tr><td align="left" valign="bottom">Nuak1</td><td align="left" valign="bottom">Clmp</td><td align="left" valign="bottom">Adgrl3</td><td align="left" valign="bottom">Ncald</td><td align="left" valign="bottom">Mmp16</td></tr><tr><td align="left" valign="bottom">Tgfb2</td><td align="left" valign="bottom">Alpk2</td><td align="left" valign="bottom">Svil</td><td align="left" valign="bottom">Zic4</td><td align="left" valign="bottom">Hhip</td></tr><tr><td align="left" valign="bottom">Sfrp1</td><td align="left" valign="bottom">Kctd1</td><td align="left" valign="bottom">Mob3b</td><td align="left" valign="bottom">Dlc1</td><td align="left" valign="bottom">Tpx2</td></tr><tr><td align="left" valign="bottom">Sncaip</td><td align="left" valign="bottom">Meg3</td><td align="left" valign="bottom">Trabd2b</td><td align="left" valign="bottom">Cdc45</td><td align="left" valign="bottom">Ndc80</td></tr><tr><td align="left" valign="bottom">Tenm3</td><td align="left" valign="bottom">Samd5</td><td align="left" valign="bottom">Rmst</td><td align="left" valign="bottom">Gatm</td><td align="left" valign="bottom">Bub1b</td></tr><tr><td align="left" valign="bottom">Cdh2</td><td align="left" valign="bottom">Nrk</td><td align="left" valign="bottom">Prrx1</td><td align="left" valign="bottom">Ssc5d</td><td align="left" valign="bottom">Hmmr</td></tr><tr><td align="left" valign="bottom">Iqgap2</td><td align="left" valign="bottom">Piezo2</td><td align="char" char="." valign="bottom">5330434G04Rik</td><td align="left" valign="bottom">Phactr2</td><td align="left" valign="bottom">Kank4</td></tr><tr><td align="left" valign="bottom">App</td><td align="left" valign="bottom">Robo1</td><td align="left" valign="bottom">Zfhx3</td><td align="left" valign="bottom">Ppp1r14c</td><td align="left" valign="bottom">Tmeff2</td></tr><tr><td align="left" valign="bottom">Pgam2</td><td align="left" valign="bottom">Col1a2</td><td align="left" valign="bottom">Foxp2</td><td align="left" valign="bottom">Agl</td><td align="left" valign="bottom">Nr4a1</td></tr><tr><td align="left" valign="bottom">Rspo3</td><td align="left" valign="bottom">Cntrl</td><td align="left" valign="bottom">Mpp6</td><td align="left" valign="bottom">Tox3</td><td align="left" valign="bottom">Aurkb</td></tr><tr><td align="left" valign="bottom">Cdon</td><td align="left" valign="bottom">Mllt3</td><td align="left" valign="bottom">Crispld1</td><td align="left" valign="bottom">Aurka</td><td align="left" valign="bottom">Lrrtm3</td></tr><tr><td align="left" valign="bottom">Ebf3</td><td align="left" valign="bottom">Peg3</td><td align="left" valign="bottom">Eya1</td><td align="left" valign="bottom">Cdh15</td><td align="left" valign="bottom">Cenpq</td></tr></tbody></table></table-wrap></sec><sec id="s2-3"><title><italic>Myf5</italic>-derived lineage contributes to connective tissue cells in the absence of neural crest</title><p>Given that the number of cells examined in the EOM and pharyngeal arch mesodermal clusters from the E10.5 dataset was lower than for anterior somites, we decided to validate the relevance of Myf5-derived non-myogenic cells in these cranial regions directly in vivo. We thus examined the EOM, larynx and upper back muscles in the early fetus at E14.5 using a <italic>Myf5</italic>-lineage reporter mouse (<italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>TdTomato/+</sup></italic>) combined with a contemporary reporter for Pdgfra (<italic>Pdgfra<sup>H2BGFP/+</sup></italic>) (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Notably, we observed GFP+ TOM+ double-positive cells in regions of EOM, laryngeal and upper back muscles that are partially or fully deprived of neural crest (<xref ref-type="bibr" rid="bib1">Adachi et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Comai et al., 2020</xref>; <xref ref-type="bibr" rid="bib38">Heude et al., 2018</xref>; <xref ref-type="fig" rid="fig3">Figure 3A–C'</xref>). Conversely, no double-positive cells were detected in muscles that are fully embedded in neural crest derived mesenchyme such as mandibular and tongue muscles (<xref ref-type="bibr" rid="bib38">Heude et al., 2018</xref>; <xref ref-type="fig" rid="fig3">Figure 3D–E'</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Myf5-derived mesodermal connective tissue partially compensates for the lack of neural crest.</title><p>(<bold>A-E'</bold>) Transverse sections of an E14.5 <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>TdTomato/+</sup>; Pdgfra<sup>H2BGFP/+</sup></italic> embryo immunostained for Myod/Myog. White arrowheads indicate cells double-positive GFP/TOM and negative for Myod/Myog (n = 3 embryos). (<bold>F-I'</bold>) Transverse cryosections of the EOM at E13.5 of <italic>Wnt1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup>; Myf5<sup>nlacZ/+</sup></italic> (<bold>G,I</bold>) and <italic>Mesp1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup>; Myf5<sup>nlacZ/+</sup></italic> (<bold>F,H</bold>) immunostained for β-gal, at the level of the medial attachment (<bold>F,G</bold>) and lateral muscle masses (<bold>H,I</bold>). Yellow arrowheads indicate Myf5-expressing cells in the context of mesodermal and neural crest lineages. Note that Myf5-expressing cells are mGFP<sup>+</sup> in the Mesp1 lineage and mGFP<sup>-</sup> in the Wnt1 lineage. Red arrowheads indicate neural-crest cells that are excluded from the <italic>Myf5</italic> lineage (n = 2 embryos for each). (<bold>J</bold>) Scatter plots of the proportion of double positive cells in E14.5 <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>TdTomato/+</sup>; Pdgfra<sup>H2BGFP/+</sup></italic> embryos in various regions throughout the EOM (the line is the mean, each dot is a tissue section, each color is a different embryo, n = 3 embryos). (<bold>K</bold>) Scheme highlighting the quantified regions in (<bold>J</bold>) and summarising the contribution of each population to periocular connective tissues. TOM: TdTOMATO.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Excel table summarizing the quantification displayed on <xref ref-type="fig" rid="fig3">Figure 3J</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70235-fig3-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig3-v3.tif"/></fig><p>Mesenchymal tissues associated with the EOM arise from mesoderm in its most dorso-medial portion and from neural crest in its ventro-lateral portion (<xref ref-type="bibr" rid="bib17">Comai et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Kuroda et al., 2021</xref>). This dual origin makes it a prime candidate to explore the relative contribution of <italic>Myf5</italic>-derived cells to the associated connective tissues within a single functional unit. Using <italic>Wnt1<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup>; Myf5<sup>nlacZ/+</sup></italic> (NCC tracing with <italic>Wnt1</italic>) and <italic>Mesp1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup>;Myf5<sup>nlacZ/+</sup></italic> (mesoderm tracing with <italic>Mesp1</italic>) at E13.5, we found that GFP+ cells that expressed <italic>Myf5</italic> (β-gal+) were exclusively present in <italic>Mesp1</italic>-derived domains and absent from the <italic>Wnt1</italic> lineage (<xref ref-type="fig" rid="fig3">Figure 3F–I'</xref>). To further evaluate the contribution of Myf5-derived cells to connective tissues in either domain, we re-examined the <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>TdTomato/+</sup>; Pdgfra<sup>H2BGFP/+</sup></italic>mouse line and quantified the percentage of GFP+ TOM+ cells in the EOM. As expected, we observed a medio-lateral gradient of <italic>Myf5</italic>-lineage contribution to EOM-associated connective tissues by E14.5, and this was anticorrelated with the local contribution of neural crest cells to connective tissues (<xref ref-type="fig" rid="fig3">Figure 3J–K</xref>). Thus, in agreement with our scRNAseq velocity analysis, these observations suggest that the mesodermal <italic>Myf5</italic>-lineage contributes to muscle-associated connective tissue in domains that are deprived of neural crest mesenchyme.</p></sec><sec id="s2-4"><title>Myf5-derived cells can maintain a molecular crosstalk following bifurcation into myogenic and connective tissue fates</title><p>To identify the transition between these two fates, we generated an additional sc-RNAseq dataset based on <italic>Myf5</italic>-lineage tracing at E11.5 (<italic>Myf5<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic>) and produced RNA velocity streams (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). We focused on the EOM and anterior somites, which were clearly distinguished as independent clusters based on the expression of <italic>Alx4</italic> (<xref ref-type="bibr" rid="bib10">Bothe and Dietrich, 2006</xref>) and <italic>Pax3</italic> (<xref ref-type="bibr" rid="bib38">Heude et al., 2018</xref>), respectively (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). In agreement with the E10.5 mesodermal (<italic>Mesp1</italic>) sc-RNAseq dataset, these progenitors presented a strong dichotomy in <italic>Pdgfa</italic> and <italic>Pdfgra</italic> expression between myogenic and non-myogenic cells, respectively (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Moreover, RNA velocity suggested more myogenic to non-myogenic conversion (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E-H</xref>). To explore further the cell fate transition in these regions, we used a recently described approach by creating a ‘Coexpression score’ based on myogenic and non-myogenic signatures (<xref ref-type="bibr" rid="bib40">Kameneva et al., 2021</xref>) (see Materials and methods, <xref ref-type="fig" rid="fig4">Figure 4C</xref>). This analysis revealed that individual cells undergo a progressive switch from myogenic to non-myogenic gene expression along the inferred trajectories, where cells at the transition zone shut off the myogenic program and start activating fibrogenic genes (<xref ref-type="fig" rid="fig4">Figure 4C</xref> heatmap).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Maintenance of signaling cues between Myf5-derived myogenic and non-myogenic cells in EOM.</title><p>(<bold>A–D</bold>) scRNAseq analysis of the <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5 dataset (2 datasets of 2 embryos were aggregated to generate this data, see Materials and methods). (<bold>A</bold>) UMAPs of <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5 RNA velocity trajectories. (<bold>B</bold>) Expression plots of <italic>Alx4</italic> and <italic>Pax3</italic>, highlighting EOM and Anterior somite clusters, respectively. (<bold>C</bold>) Plots of Myogenic and Non-myogenic signatures, Coexpression score and heatmaps of top markers, highlighting the transition population in EOM and anterior somites. Cells are ordered based on their non-myogenic signature score (increasing). The coexpression score is the product of the myogenic and non-myogenic signatures. Cells presenting a coexpression score higher than 0.20 are highlighted in yellow. These cells represent the transition between the myogenic and non-myogenic fates. (<bold>D</bold>) UMAP of the EOM subset revealing the bipartite fate of <italic>Myf5</italic>-expressing cells. (<bold>E-G’</bold>) RNAscope on <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E14.5 tissue sections with <italic>Pdgfra</italic> (cyan) and <italic>Pdgfa</italic> (red) probes (<bold>E-E’’</bold>), <italic>Bmprb1</italic> (red) and <italic>Bmp4</italic> (cyan) probes (<bold>F-F’</bold>) and <italic>Ephb1</italic> (red) and <italic>Efnb1</italic> (cyan) probes (<bold>G-G’</bold>). <italic>Myf5</italic>-derived cells are labelled by membrane GFP staining (n = 3 embryos each). Red and yellow arrowheads indicate <italic>Myf5</italic>-derived myogenic and non-myogenic cells respectively. The dotted lines highlight the boundary of the muscle masses. (<bold>H</bold>) Quantification of the Ligand-Receptor scores for each pair (see Materials and methods). Note that these ratios are negative in the case of Bmp and Eph (signaling from non-myogenic to myogenic) but positive for Pdgf (signaling from myogenic to non-myogenic). (<bold>G</bold>) Model of myogenic and non-myogenic cell communication following bifurcation from a bipotent cell.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Excel table summarizing the quantification displayed on <xref ref-type="fig" rid="fig4">Figure 4H</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70235-fig4-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>FACS strategy, preprocessing metrics, expression patterns, and RNA velocity metrics of the <italic>Myf5</italic>-derived E11.5 dataset.</title><p>(<bold>A</bold>) Gating strategy used to isolate by FACS <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> cells. The Alexa Fluor 488 channel was used to identify GFP+ cells. The Alexa Fluor 405 channel was used to identify the Calcein Blue+ live cells. The PE-Texas Red channel was used to discard mTomato+ cells (non recombined) and Propidium Iodide+ cells. The percentage of cells captured by each gate is displayed on each plot. (<bold>B</bold>) Violin plots of gene count, UMI count and mitochondrial fraction for overall dataset. (<bold>C</bold>) Violin plots of gene count and UMI count by cluster. (<bold>D</bold>) Expression patterns of <italic>Myf5, Myod, Myog, Pdgfa, Pdgfra</italic>, and <italic>Col1a1</italic> in the <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5 dataset. Note that Myf5+ cells were overwhelmingly Pdgfra- and Myf5+/Pdgfra+ cells represent 5.5% of all cells (i.e. expressing at least one transcript of both genes). Pdgfra+ cells represent 56% of all cells. (<bold>E</bold>) UMAP of <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5 with overlaid velocity and cell cycle phase. (<bold>F–H</bold>) Quality control metrics of scvelo, including velocity length, velocity confidence and spliced/unspliced abundance in overall dataset and by cluster (n = 2 pooled datasets).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig4-figsupp1-v3.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Kinase signaling complementarity in the EOM at E11.5.</title><p>(<bold>A</bold>) GO Molecular Function network of top 100 driver genes of the <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5 EOM dataset (see <xref ref-type="table" rid="table1">Table 1</xref>), including relative contribution of each cluster (myogenic and non-myogenic) to the term and significance levels. Insert show the significance of each term. (<bold>B</bold>) UMAPs of the <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5 EOM dataset showing the expression of kinase ligands (left side) and the velocity of their corresponding receptors (right side). Note the complementary patterns of the L/R pairs (n = 2 pooled datasets).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig4-figsupp2-v3.tif"/></fig></fig-group><p>To investigate in more detail potential paracrine cell-cell communication between myogenic and non-myogenic cells, we examined their expression patterns within the EOM, given its well-defined morphology (<xref ref-type="bibr" rid="bib17">Comai et al., 2020</xref>), and its strong myogenic/non-myogenic bi-directional cell-fate (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). We performed single molecule fluorescent in situ hybridization (RNAscope) for <italic>Pdgfa</italic> and <italic>Pdgfra</italic> on E14.5 lineage-traced <italic>Myf5<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup></italic> fetuses (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). In accordance with the scRNAseq analysis, we observed cells exhibiting a mostly non-overlapping, complementary pattern of <italic>Pdgfa</italic> and <italic>Pdgfra</italic> transcripts within the <italic>Myf5</italic>-derived lineage, while retaining anatomical proximity, even at later stages of EOM development.</p><p>Gene set enrichment analysis of EOM myogenic and non-myogenic driver genes showed that transmembrane receptor protein kinase and SMAD activity were shared terms between the two clusters, suggesting that specific complementary signaling networks could be actively maintained between these two populations (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). Both signaling pathways were reported to act as inhibitors of myogenic differentiation and could therefore be associated with progenitor cell maintenance (<xref ref-type="bibr" rid="bib3">Arnold et al., 2020</xref>; <xref ref-type="bibr" rid="bib19">Cossu et al., 2000</xref>). Notably, <italic>Bmpr1b</italic> and <italic>Ephb1</italic> were among the top 100 driver genes of the myogenic EOM compartment, suggesting that myogenic commitment is associated with upregulation of these kinase receptors in the EOM (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Strikingly, two of their respective ligands, <italic>Bmp4</italic> and <italic>Efnb1</italic>, were preferentially expressed in non-myogenic cells. Analysis of their expression patterns in E14.5 embryos by RNAscope validated these complementary expression patterns in adjacent muscle and connective tissue domains (<xref ref-type="fig" rid="fig4">Figure 4F–H</xref>). These results favor a model where paracrine signaling networks operate between myogenic and non-myogenic <italic>Myf5</italic>-derived cells (<xref ref-type="fig" rid="fig4">Figure 4I</xref>), while their cellular juxtaposition is maintained through fetal stages.</p></sec><sec id="s2-5"><title>Obstructing myogenesis expands connective tissue formation from bipotent cells</title><p>The directional trajectories identified by RNA velocity in the EOM at E11.5 showed a strong bidirectionality in fate with a higher velocity confidence index at each end of the myogenic and non-myogenic domains, and lower at their interface (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). This suggested that cells at the interface are bipotential while cells located on either side of this central region are committed either to a myogenic-or non-myogenic fate. To identify the regulatory factors underlying this potential bipotency, we used SCENIC, a regulatory network inference algorithm (<xref ref-type="bibr" rid="bib2">Aibar et al., 2017</xref>). This tool allows regrouping of sets of correlated genes into regulons (each regulon consists of a transcription factor and its targets) based on binding motifs and co-expression. The top regulons of this analysis revealed active transcription factors underlying myogenic and non-myogenic cell fates in the EOM at E11.5. Notably, <italic>Myf5</italic>, <italic>Pitx1</italic>, <italic>Mef2a,</italic> and <italic>Six1</italic>, transcription factors known to be implicated in myogenic development (<xref ref-type="bibr" rid="bib11">Buckingham and Rigby, 2014</xref>), appeared among the top regulons in myogenic cells whereas <italic>Fli1</italic>, <italic>Ebf1</italic>, <italic>Ets1</italic>, <italic>Foxc1</italic>, <italic>Meis1,</italic> and <italic>Six2</italic>, genes known for their involvement in adipogenic, vascular, mesenchymal and tendon development (<xref ref-type="bibr" rid="bib39">Jimenez et al., 2007</xref>; <xref ref-type="bibr" rid="bib52">López-Delgado et al., 2020</xref>; <xref ref-type="bibr" rid="bib63">Noizet et al., 2016</xref>; <xref ref-type="bibr" rid="bib80">Truong and Ben-David, 2000</xref>; <xref ref-type="bibr" rid="bib87">Whitesell et al., 2019</xref>; <xref ref-type="bibr" rid="bib90">Yamamoto-Shiraishi and Kuroiwa, 2013</xref>), constituted some of the highly active non-myogenic transcription factors (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Interestingly, recent work uncovered <italic>Fli1</italic> as a potential regulator of vascular fate in multipotent myogenic progenitors (<xref ref-type="bibr" rid="bib28">Ferdous et al., 2021</xref>). Accordingly, we found that <italic>Scube1</italic>, a gene known for its involvement in vasculature development, was upregulated in the Pdgfra+ non-myogenic fraction of the EOM (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). RNAscope in situ hybridization confirmed these findings and showed that <italic>Scube1</italic> was expressed at the level of the EOM medial attachment at E14.5 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C-E</xref>). In addition, <italic>Scube1</italic> was reported to promote BMP signaling (<xref ref-type="bibr" rid="bib51">Liao et al., 2016</xref>). Thus, the EOM tendon attachment seems to rely on transcription factors and markers that are typically vascular, hence suggesting that some of them are coopted.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Disruption of <italic>Myf5</italic> increases the connective tissue output from bipotent cells.</title><p>(<bold>A</bold>) Heatmap of top regulons (transcription factor and associated targets) of the EOM subset of the <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5 dataset. The suffix ‘_extended’ indicates that the regulon includes motifs that have been linked to the TF by lower confidence annotations, for instance, inferred by motif similarity. Number in brackets indicates number of genes comprising the regulon (n = 2 pooled datasets). (<bold>B–C</bold>) Transverse sections of <italic>Myf5<sup>nlacZ/+</sup></italic> (<bold>B</bold>), and <italic>Myf5<sup>nlacZ/nlacZ</sup></italic> (<bold>C</bold>) embryos in the EOM region at E12.5 immunostained for β-gal (green), and Myod/Myog/Pax7 (red). Red arrowheads indicate β-gal/ Myod/Myog/Pax7 double positive cells in control EOM/Masseter and in mutant Masseter. Asterisk highlights the lack of myogenic progenitors in the EOM region of the mutant embryo, indicated by the absence of Myod/Myog/Pax7 staining. (<bold>D-E’</bold>) Transverse sections of <italic>Myf5<sup>nlacZ/+</sup></italic> (<bold>D-D'</bold>), and <italic>Myf5<sup>nlacZ/nlacZ</sup></italic> (<bold>E-E'</bold>) in the EOM region at E12.5 immunostained for β-gal (green), Sox9 (red), and Myod/Myog/Pax7 (gray). Yellow arrowheads indicate β-gal/Sox9 double positive cells and show an expansion of this cell population in the mutant. (<bold>F</bold>) Quantification of proportion of β-gal+;Sox9+ double positive cells in the total Sox9+ population of the EOM and Masseter muscles. Each dot is a different sample, the center line of the boxplot is the median value. (n = 3 embryos, p-values were calculated using a two-sided Mann-Whitney U test). (<bold>G-I’</bold>) Transverse sections of <italic>Myod<sup>iCre/+</sup>; Rosa26<sup>TdTomato/+</sup>; Pdgfra<sup>H2BGFP/+</sup></italic> embryos at E14.5 immunostained for Myod/Myog (committed and differentiating myoblasts) in the extraocular (<bold>G-G’’</bold>), mandibular (<bold>H-H’</bold>), and back muscles (<bold>I-I’</bold>). White arrowhead indicates double positive cells (GFP+ TOM+). (J) Quantification of double positive cells (GFP+ TOM+) in EOM, mandibular muscles and back muscles per 100 μm<sup>2</sup> area on <italic>Myod<sup>iCre/+</sup>; Rosa26<sup>TdTomato/+</sup>; Pdgfra<sup>H2BGFP/+</sup></italic> sections shown in E-G (n = 4 embryos). (K) Model of lineage progression from bipotent cells in a <italic>Myf5</italic> null background.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Excel table summarizing the quantification displayed on <xref ref-type="fig" rid="fig5">Figure 5F</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70235-fig5-data1-v3.xlsx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Excel table summarizing the quantification displayed on <xref ref-type="fig" rid="fig5">Figure 5J</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70235-fig5-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>The vascular marker <italic>Scube1</italic> is expressed in <italic>Myf5</italic>-derived non-myogenic cells in the EOM.</title><p>(<bold>A</bold>) UMAP of <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5 EOM dataset illustrating velocity confidence and velocity length. Higher confidence is found on both ends of the EOM cluster. (<bold>B</bold>) Expression pattern of <italic>Scube1</italic> in the EOM subset (mostly in the non-myogenic compartment). (<bold>C-C’’</bold>) Combined RNAscope for <italic>Scube1</italic> and Myod/Myog/GFP immunostaining on transverse sections of <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> at E14.5. (<bold>D</bold>) Model of the EOM muscle vs EOM origin compartmentalization used for quantification in (E). (<bold>E</bold>) Quantification of <italic>Scube1</italic> signal in each compartment (n = 2 embryos).</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Excel table summarizing the quantification displayed on <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70235-fig5-figsupp1-data1-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig5-figsupp1-v3.tif"/></fig></fig-group><p>Given that <italic>Myf5</italic> appeared itself as a top myogenic regulon (<xref ref-type="fig" rid="fig5">Figure 5A</xref>), we interrogated the fate of <italic>Myf5</italic>-expressing progenitors in a <italic>Myf5<sup>nlacZ/nlacZ</sup></italic> null embryos at E12.5 (<xref ref-type="fig" rid="fig5">Figure 5B–E’</xref>). As previously reported, the EOMs are absent in this mutant (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, asterisk) (<xref ref-type="bibr" rid="bib70">Sambasivan et al., 2009</xref>). Interestingly, some β-gal+ cells were found in the cartilage primordium (Sox9+) of the EOM in the heterozygous control indicating that cells with recent <italic>Myf5</italic> activity diverged to this non-myogenic fate (<xref ref-type="fig" rid="fig5">Figure 5D–D'</xref>). Notably, disruption of <italic>Myf5</italic> activity led to a threefold increase in the proportion of non-myogenic <italic>Myf5</italic>-derived cells in this region (<xref ref-type="fig" rid="fig5">Figure 5E–F</xref>). In contrast, no double-positive cells were found in the masseter, a muscle fully embedded in neural crest-derived connective tissue, even in the absence of <italic>Myf5</italic> (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). <italic>Myf5</italic> expression is thus necessary to maintain a balance between myogenic and non-myogenic cell fates of Myf5+ progenitors only in neural crest-depleted regions. In contrast, very few Pdgfra+ cells were found to be derived from <italic>Myod</italic> expressing cells in <italic>Myod<sup>iCre</sup>;Rosa26<sup>TdTomato/+</sup>;Pdgfra<sup>H2BGFP/+</sup></italic> fetuses at E14.5, particularly in the EOM and the back muscles (about 3 and 1.5 cells per 100 μm<sup>2</sup> of muscle, respectively)(<xref ref-type="fig" rid="fig5">Figure 5G, I, J</xref>). Accordingly, the masseter lacked <italic>Myod</italic>-derived connective tissue cells (<xref ref-type="fig" rid="fig5">Figure 5H and J</xref>). These observations indicate that progenitors that bifurcate to myogenic and non-myogenic cell fates are present only in neural-crest depleted regions. This property is associated primarily with <italic>Myf5</italic> expression, as subsequent activation of <italic>Myod</italic> within this lineage appears to lock cell fate into the myogenic program and suppress their connective tissue potential (<xref ref-type="fig" rid="fig5">Figure 5K</xref>).</p></sec><sec id="s2-6"><title>Myf5-derived connective tissues are observed in fetal stages</title><p>Although we identified <italic>Myf5</italic>-derived non-myogenic cells in various regions of the embryo, it was not clear if this population was continuously generated throughout development. To address this issue, we performed two more scRNAseq experiments at E12.5 and E14.5, using contemporary <italic>Myf5</italic> labeling, which led to much fewer non-myogenic cells that could be captured (<italic>Myf5<sup>GFP-P/+</sup></italic>; <xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). In accordance with the earlier datasets, some cells that appeared to belong to muscle anlagen of EOM, somites and caudal arches progressed toward a non-myogenic state (<xref ref-type="fig" rid="fig6">Figure 6A–C’</xref>). To assess the identity of these cells, we performed a gene set enrichment network analysis combining the differentially expressed genes of non-myogenic clusters of all stages. We found that all stages contributed relatively equally to each ‘GO Molecular Function’ and ‘Reactome pathways’ terms despite their relatively diverse gene expression signatures (<xref ref-type="fig" rid="fig6">Figure 6D–E’</xref>, <xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). This suggests that these non-myogenic cells are relatively homogeneous in gene signatures throughout cranial muscles. Highly significant terms hinted at a myogenic-supporting role, providing muscle progenitors with extracellular matrix components, and contributing to neuronal guidance (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). Among these terms, presence of Pdgf signalling and receptor kinase activity indicated, once again, that the interactions found in the EOM could occur also at later stages in various craniofacial muscles that are deprived of neural crest derived connective tissue.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Myf5-derived non-myogenic cells are generated continuously up to fetal stages.</title><p>(<bold>A-C'</bold>) RNA velocity plots of <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>mTmG/+</sup></italic> E11.5, <italic>Myf5<sup>GFP-P/+</sup></italic> E12.5 and <italic>Myf5<sup>GFP-P/+</sup></italic> E14.5 datasets (n = 2 pooled datasets, n = 1 embryo and n = 1 embryo, respectively) displaying cell-type annotation (<bold>A–C</bold>) and myogenic and non-myogenic clustering (<bold>A’-C’</bold>). The dotted boxes highlight the transitions to non-myogenic clusters in each dataset. (<bold>D–E</bold>) Gene ontology network of GO Molecular Function and Reactome pathway performed on combined top 100 markers using Cluego. These terms were generated using the sum of all differentially expressed genes of the non-myogenic clusters across all datasets (see Materials and methods). (<bold>D’-E’</bold>) Relative contribution of each stage to term node represented as piecharts (i.e. the proportion of genes underlying this term coming from that stage). Dotted boxes highlight the shared tyrosine kinase and PDGF signaling pathways.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig6-v3.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>FACS strategy, preprocessing metrics, expression patterns, and RNA velocity metrics in the <italic>Myf5<sup>GFP-P/+</sup></italic>E12.5 dataset.</title><p>(<bold>A</bold>) Gating strategy used to isolate by FACS <italic>Myf5<sup>GFP-P/+</sup></italic> cells. The FITC channel was used to identify GFP+ cells. The BV421 was used to identify the Calcein Blue+ live cells. The PE-Texas Red channel was used to discard Propidium Iodide+ cells. The percentage of cells captured by each gate is displayed on each plot. (<bold>B</bold>) Violin plots of gene count, UMI count and mitochondrial fraction for overall dataset. (<bold>C</bold>) Violin plots of gene count and UMI count by cluster. (<bold>D</bold>) Expression patterns of <italic>Myf5, Myod, Myog, Pdgfa, Pdgfra</italic>, and <italic>Col1a1</italic> in the <italic>Myf5<sup>GFP-P/+</sup></italic> E12.5 dataset. Note that Myf5+ cells were overwhelmingly Pdgfra- and Myf5+/Pdgfra+ cells represent 0.5% of all cells (i.e. expressing at least one transcript of both genes). Pdgfra+ cells represent 3% of all cells. (<bold>E</bold>) UMAP of <italic>Myf5<sup>GFP-P/+</sup></italic> E12.5 with overlaid velocity and cell cycle phase. (<bold>F–H</bold>) Quality control metrics of scvelo, including velocity length, velocity confidence and spliced/unspliced abundance in overall dataset and by cluster (n = 1 embryo).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig6-figsupp1-v3.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>FACS strategy, preprocessing metrics, expression patterns and RNA velocity metrics in the <italic>Myf5<sup>GFP-P/+</sup></italic> E14.5 dataset.</title><p>(<bold>A</bold>) Violin plots of gene count, UMI count and mitochondrial fraction for overall dataset. (<bold>B</bold>) Violin plots of gene count and UMI count by cluster. (<bold>C</bold>) Expression patterns of <italic>Myf5, Myod, Myog, Pdgfa, Pdgfra</italic>, and <italic>Col1a1</italic> in the <italic>Myf5<sup>GFP-P/+</sup></italic> E14.5 dataset. Note that Myf5+ cells were overwhelmingly Pdgfra- and Myf5+/Pdgfra+ cells represent 0.15% of all cells (i.e. expressing at least one transcript of both genes). Pdgfra+ cells represent 7% of all cells (n = 1 embryo). (<bold>D</bold>) UMAP of <italic>Myf5<sup>GFP-P/+</sup></italic> E14.5 with overlaid velocity and cell cycle phase (n = 1 embryo). (<bold>E–G</bold>) Quality control metrics of scvelo, including velocity length, velocity confidence and spliced/unspliced abundance in overall dataset and by cluster (n = 1 embryo).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig6-figsupp2-v3.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>Non-myogenic <italic>Myf5</italic>-derived cells display a similar gene ontology.</title><p>Gene ontology analysis for Reactome pathways, including genes underlying each term, and their representation in each dataset generated using Cluego based on top 100 differentially expressed genes of the non-myogenic clusters (see Materials and methods, E10.5: n = 2 pooled datasets, E11.5: n = 2 pooled datasets, E12.5: n = 1 embryo and E14.5: n = 1 embryo).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig6-figsupp3-v3.tif"/></fig></fig-group></sec><sec id="s2-7"><title>A novel regulatory network underlies the non-myogenic cell fate</title><p>Myf5+ bipotent progenitors were observed at multiple stages and anatomical locations, and they yielded a relatively homogeneous population expressing common markers associated with extracellular matrix components, cell adhesion molecules, and kinase signalling. To assess whether the regulatory mechanisms guiding this transition are distinct in different locations in the head, we set out to explore the common molecular switches underlying cell fate decisions. To do so, we developed a pipeline where we combined the list of driver genes at the start of the non-myogenic trajectory (<xref ref-type="table" rid="table1">Table 1</xref>) with the most active regulons in the non-myogenic region (Materials and methods, code in open access). This resulted in a network consisting of the most active transcription factors and the most transcriptionally dynamic genes found at the non-myogenic branchpoint. We performed this operation for each dataset independently and displayed them as individual networks (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A-D</xref>). Finally, we overlapped the list of these ‘driver regulators’ to identify the common transcription factors guiding the non-myogenic cell fate decision (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Notably, <italic>Foxp2</italic>, <italic>Hmga2</italic>, <italic>Meis1</italic>, <italic>Meox2,</italic> and <italic>Tcf7l2</italic> were identified in all four scRNAseq datasets as key driver regulators, and thus are likely to play significant role in the non-myogenic transition (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <xref ref-type="table" rid="table2">Table 2</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>A shared program involving Forkhead-box transcription factors supports non-myogenic fate transition at various stages and anatomical locations.</title><p>(<bold>A</bold>) Barplot displaying frequency of appearance of most predominant transcription factors as driver regulators (4 = present in all four datasets as driver regulon, 1 = present in a single dataset). (<bold>B-D’’</bold>) Transverse sections of an E12.5 <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>TdTomato/+</sup>; Pdgfra<sup>H2BGFP/+</sup></italic> embryo immunostained for Foxp2 at the level of the EOM (<bold>B-B’’</bold>), Mandibular muscles (<bold>C-C’’</bold>), and Back muscles (<bold>D-D’’</bold>). Yellow arrowheads indicated the double positive cells to better appreciate Foxp2 intensity in <italic>Myf5</italic>-derived cells. (<bold>E</bold>) Quantification of Foxp2 signal intensity in TOM+ (<italic>Myf5</italic>-derived) cells in each muscle (n = 3 embryos). Statistical test performed: Mann-Whitney U test. (<bold>F</bold>) FACS plots of dissected E12.5 <italic>Myf5<sup>Cre/+</sup>; Rosa26<sup>TdTomato/+</sup>; Pdgfra<sup>H2BGFP/+</sup></italic> embryos (head region here) highlighting the <italic>Myf5</italic>-derived GFP- TOM+ population transitioning to the GFP+ TOM+ population. Each plot was generated on the population gated in the previous one (‘Singlets’, ‘TOM+’ and ‘NonFaps’). FAPS:Fibroadipogenic progenitors, a denomination for resident Pdgfra+ cells. (<bold>G</bold>) Quantification of the transitioning population in Head, Limb and Trunk. Proportion of transitioning cells is calculated as the number of Alexa488+/Total cell number in the ‘NonFAPs’ gate. Note that the Head region is mostly populated by muscles embedded in neural crest (n = 5 embryos). TOM: TdTOMATO.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Excel table summarizing the quantification displayed on <xref ref-type="fig" rid="fig7">Figure 7E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70235-fig7-data1-v3.xlsx"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Excel table summarizing the quantification displayed on <xref ref-type="fig" rid="fig7">Figure 7G</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-70235-fig7-data2-v3.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig7-v3.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Wnt/β-cat positive feedback loop may promote non-myogenic cell fate.</title><p>(<bold>A–D</bold>) Driver genes and regulatory networks (regulons) were produced for each stage independently, and a stage-specific network of active transcription factor and associated driver gene targets was built (n = 2 pooled datasets, n = 2 pooled datasets, n = 1 embryo and n = 1 embry, respectively). The size of nodes corresponds to the number of edges (connections) they have, i.e. the number of driver genes the transcription factor regulates. (<bold>E–H</bold>) Dotplot of the expression levels and percent of <italic>Axin2</italic> and <italic>Dkk2</italic> in the myogenic and the non-myogenic portions of all four datasets.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig7-figsupp1-v3.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>Model of Myf5+ bipotent progenitors giving rise to muscle and associated connective tissues.</title><p>Model for bipotent Myf5+/Pdgfa+ progenitors giving rise to myogenic and non-myogenic cells; discrete parts of the head deprived of neural crest are indicated. Upon activation of a set of transcription factors including <italic>Prrx1/2</italic>, <italic>Foxp2</italic>, <italic>Hmga2</italic>, <italic>Meis1</italic>, <italic>Meox2</italic>, <italic>Fli1</italic>, <italic>Twist1</italic>, <italic>Ets1</italic>, <italic>Tcf7l2,</italic> and <italic>Tcf4</italic>, a fibrogenic fate is acquired. A molecular dialogue is initiated at the branchpoint including extracellular matrix components and kinase signalling such as Pdgf, Ephrins, and Bmps. The non-myogenic fate may be maintained cell-autonomously by a canonical Wnt-positive feedback loop.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-70235-fig7-figsupp2-v3.tif"/></fig></fig-group><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Driver regulators of non-myogenic fate in each dataset.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom">E10.5</th><th align="left" valign="bottom">E11.5</th><th align="left" valign="bottom">E12.5</th><th align="left" valign="bottom">E14.5</th></tr></thead><tbody><tr><td align="left" valign="bottom">Foxp2</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Hmga2</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Meis1</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Meox2</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Tcf7l2</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Fli1</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Lef1</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Prrx1</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Prrx2</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Six2</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Creb3l1</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Ebf1</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Ets1</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Foxp4</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Hoxb3</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Klf6</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Nfatc4</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Nfib</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Pax7</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Pbx1</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Rreb1</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Tbx15</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Tcf4</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Twist1</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Zic4</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Zmiz1</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Ar</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Arid5b</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td></tr><tr><td align="left" valign="bottom">Atf3</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(+)</td></tr><tr><td align="left" valign="bottom">Chd2</td><td align="left" valign="bottom">(+)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td><td align="left" valign="bottom">(-)</td></tr></tbody></table><table-wrap-foot><fn><p>(+): Present, (-): Absent.</p></fn></table-wrap-foot></table-wrap><p>Forkhead box transcription factors FOXC1 and FOXC2 were reported to regulate the balance between myogenic and vascular lineages within somites (<xref ref-type="bibr" rid="bib48">Lagha et al., 2009</xref>; <xref ref-type="bibr" rid="bib55">Mayeuf-Louchart et al., 2016</xref>). Interestingly, <italic>Foxc1</italic> has been reported to promote both cranial vasculature and cranial cartilage development in zebrafish (<xref ref-type="bibr" rid="bib87">Whitesell et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">Xu et al., 2021</xref>). FOXP2 immunostaining on <italic>Myf5<sup>Cre/+</sup>;Rosa26<sup>TdTom/+</sup>;Pdgfra<sup>H2BGFP/+</sup></italic> E12.5 embryos showed that the <italic>Myf5</italic>-derived EOM cells expressed a relatively high level of <italic>Foxp2</italic> compared to mandible and trunk muscles, consistent with their apparent high contribution to connective tissue (<xref ref-type="fig" rid="fig7">Figure 7B–E</xref>).</p><p>To gain further insights into the transitioning population, we performed FACS analysis of dissected head, limb and trunk regions of <italic>Myf5<sup>Cre/+</sup>;Rosa26<sup>TdTom/+</sup>;Pdgfra<sup>H2BGFP/+</sup></italic> embryos at E12.5 (<xref ref-type="fig" rid="fig7">Figure 7F–G</xref>). We focused on TOM+ cells (Myf5-lineage) and assessed their GFP expression levels as a readout of their commitment toward connective tissue. This analysis identified non-FAPs cells (GFP<sup>low</sup>) transitioning towards a Pdgfra+ state in head and trunk regions but very few in the limb (<xref ref-type="fig" rid="fig7">Figure 7G</xref>). Interestingly, while trunk muscles presented the largest portion of transitioning cells (40%), a similar transitioning population was noted in the head (20%) despite a large contribution of NCC to head connective tissues. Thus, cardiopharyngeal mesoderm may have a superior potential to give rise to connective tissue compared to somite-derived progenitors in the limb (1.5%).</p><p>In addition, Tcfs and Lef1 were among the top common regulators identified, and they form a complex effector for the canonical Wnt pathway. Previous work showed that during cranial myogenesis, neural crest cells release inhibitors of the Wnt pathway to promote myogenesis (<xref ref-type="bibr" rid="bib81">Tzahor et al., 2003</xref>). It is thus tempting to speculate that in the absence of neural crest, mesoderm-derived progenitors can give rise to connective tissue by maintaining canonical Wnt activity. To test this hypothesis, we examined the expression of Axin2, a common readout for Wnt/β-cat activity (<xref ref-type="bibr" rid="bib4">Babb et al., 2017</xref>; <xref ref-type="bibr" rid="bib82">van de Moosdijk et al., 2020</xref>). Interestingly, Axin2 levels were elevated in the non-myogenic portion of all the different datasets (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1E-H</xref>). Additionally, Dkk2, which has been described as an activator of Wnt/β-cat pathway in the neural crest (<xref ref-type="bibr" rid="bib23">Devotta et al., 2018</xref>), was also found to be elevated, indicative of a putative positive-feedback loop mechanism supporting the maintenance of this population.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Distinct fates can emerge through the specification of individual cell types, or through direct lineage ancestry from bipotent or multipotent cells. Here, we addressed this issue in the context of the emergence of myogenic and associated connective tissue cells during the formation of craniofacial muscles. By combining state-the-art computational methods and in-situ analyses, we identified the transcriptional dynamics, the intercellular communication networks, and the regulators controlling the balance between complementary cell fates. Specifically, our work provides evidence for a novel mesoderm-derived bipotent cell population that gives rise to muscle and associated connective tissue cells spatiotemporally, and only in regions deprived of neural crest cells (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>).</p><p>Brown adipocytes, neurons, pericytes, and rib cartilage have been reported to express <italic>Myf5</italic> in ancestral cells (<xref ref-type="bibr" rid="bib21">Daubas et al., 2000</xref>; <xref ref-type="bibr" rid="bib35">Haldar et al., 2008</xref>; <xref ref-type="bibr" rid="bib71">Sebo et al., 2018</xref>; <xref ref-type="bibr" rid="bib75">Stuelsatz et al., 2014</xref>). Interestingly, when <italic>Myf5</italic> expression is disrupted, cells can acquire non-myogenic fates and contribute to connective tissue (this study), cartilage, and dermis (<xref ref-type="bibr" rid="bib77">Tajbakhsh et al., 1996</xref>), while others remain apparently undifferentiated (cells labeled with an asterisk in <xref ref-type="fig" rid="fig5">Figure 5C</xref>). It is likely that these cells are undergoing apoptosis as reported previously (<xref ref-type="bibr" rid="bib70">Sambasivan et al., 2009</xref>). These studies suggest that <italic>Myf5</italic>-expression alone is not sufficient to promote robust myogenic fate in multiple regions of developing embryos. Consistent with these observations, Myod+ cells do not contribute to rib cartilage (<xref ref-type="bibr" rid="bib88">Wood et al., 2020</xref>) and give rise to few connective tissue cells in the periocular and back regions (this study). These findings are also consistent with the role of <italic>Myod</italic> in defining the committed myogenic cell state and its higher chromatin-remodelling capacity compared to Myf5 (<xref ref-type="bibr" rid="bib18">Conerly et al., 2016</xref>; <xref ref-type="bibr" rid="bib79">Tapscott, 2005</xref>). In contrast to a previous study (<xref ref-type="bibr" rid="bib75">Stuelsatz et al., 2014</xref>), we found no neural-crest derived cells expressing <italic>Myf5</italic> during EOM tissue genesis at E13.5 (using <italic>Wnt1<sup>Cre/+</sup>;Rosa26<sup>mTmG/+</sup>;Myf5<sup>nlacZ/+</sup></italic>). We note that <italic>Myf5</italic>-expressing cells contribute to non-myogenic cells from early embryonic stages (E10.5) and continue to do so in the fetus, indicating that these bipotent cells persist well after muscles are established.</p><p>Here, we also identifed a core set of transcription factors specifically active in the non-myogenic cells across all datasets. We propose that these genes guide bipotent cells to a non-myogenic fate and thus confer mesenchymal properties to non-committed progenitors. Recent studies have identified anatomically distinct fibroblastic populations using single-cell transcriptomics, yet unique markers could not be identified (<xref ref-type="bibr" rid="bib58">Muhl et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Sacchetti et al., 2016</xref>), making characterisation of cell subtypes challenging. Tcf4/Tcf7l2 was identified as a master regulator of fibroblastic fate during muscle-associated connective tissue development, although it is also expressed in myogenic progenitors at lower levels (<xref ref-type="bibr" rid="bib42">Kardon et al., 2003</xref>; <xref ref-type="bibr" rid="bib54">Mathew et al., 2011</xref>; <xref ref-type="bibr" rid="bib72">Sefton and Kardon, 2019</xref>). We also report that this gene is one of the main regulators of connective tissue fate. Other transcription factors have been linked to skin fibroblast fates including <italic>Tcf4</italic>, <italic>Six2</italic>, <italic>Meox2</italic>, <italic>Egr2,</italic> and <italic>Foxs1</italic>, and their repression favors a myofibroblastic potential (<xref ref-type="bibr" rid="bib63">Noizet et al., 2016</xref>). <italic>Six2</italic> and <italic>Meox2</italic> were also identified in our analysis, which raises the question of the shared genetic programs between myofibroblastic cells and fibroblastic cells derived from progenitors primed for myogenesis during development.</p><p>Interestingly, <italic>Prrx1</italic>, a marker for lateral plate mesoderm (<xref ref-type="bibr" rid="bib25">Durland et al., 2008</xref>), was differentially expressed in the connective tissue population at various stages. Although lateral plate mesoderm is identifiable in the trunk, its anterior boundaries in the head are unclear (<xref ref-type="bibr" rid="bib65">Prummel et al., 2020</xref>). More detailed analyses of <italic>Prrx1</italic>, <italic>Isl1,</italic> and <italic>Myf5</italic> lineages need to be carried out to delineate the specific boundaries of each progenitor contribution to cranial connective tissues.</p><p>Kinase receptors have been implicated in a number of developmental programs for both muscle and associated connective tissues (<xref ref-type="bibr" rid="bib3">Arnold et al., 2020</xref>; <xref ref-type="bibr" rid="bib45">Knight and Kothary, 2011</xref>; <xref ref-type="bibr" rid="bib64">Olson and Soriano, 2009</xref>; <xref ref-type="bibr" rid="bib78">Tallquist et al., 2000</xref>; <xref ref-type="bibr" rid="bib81">Tzahor et al., 2003</xref>; <xref ref-type="bibr" rid="bib84">Vinagre et al., 2010</xref>). For example, the differentiation of fetal myoblasts is inhibited by growth factors Tgfβ and Bmp4 (<xref ref-type="bibr" rid="bib19">Cossu et al., 2000</xref>). Epha7 signaling is active in embryonic and adult myocytes and promotes their differentiation (<xref ref-type="bibr" rid="bib3">Arnold et al., 2020</xref>). Significantly, we noticed a striking and lasting complementary expression of <italic>Pdgfa</italic> and <italic>Pdgfra</italic> throughout embryonic stages, in the myogenic and non-myogenic progenitors respectively. Pdgf ligands emanating from hypaxial myogenic cells under the control of <italic>Myf5</italic> were shown to be necessary from rib cartilage development (<xref ref-type="bibr" rid="bib78">Tallquist et al., 2000</xref>; <xref ref-type="bibr" rid="bib84">Vinagre et al., 2010</xref>). Additionally, Pdgfra promotes expansion of fibroblasts during fibrosis (<xref ref-type="bibr" rid="bib64">Olson and Soriano, 2009</xref>). Interestingly, we found that <italic>Pdgfa</italic> expression was reduced in cells expressing high levels of <italic>Myog</italic> at the fetal stage (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2C</xref>). Therefore, <italic>Myf5</italic>-derived myogenic progenitor cells might guide non-myogenic <italic>Myf5</italic>-derived expansion, which in turn provides ligands and extracellular matrix components to favor myogenic development and patterning. Moreover, unlike trunk myogenesis, cranial muscle development relies on the expression of Wnt and Bmp inhibitors from surrounding tissues (<xref ref-type="bibr" rid="bib81">Tzahor et al., 2003</xref>). Interestingly, we showed that the <italic>Myf5</italic>-derived non-myogenic cells express <italic>Bmp4</italic>, <italic>Dkk2</italic>, and <italic>Axin2</italic>. Additionally, we showed that the Wnt effector complex <italic>Tcf/Lef</italic> is expressed to a lower extent in these cells. It is thus likely that these cells maintain their non-myogenic fate by promoting Bmp production and Wnt activity cell-autonomously.</p><p>Of note, another study suggested shared fate relationships between fibroblast connective tissue cells and skeletal muscle where fibroblastic cells commit to myogenic fate during limb development (<xref ref-type="bibr" rid="bib26">Esteves de Lima et al., 2021</xref>). Regarding the possibility that some non-myogenic cells may retain bipotent characteristics, our data suggests that the opposite is true during cranial muscle development. First, RNA velocity analysis did not reveal transitioning cells from non-myogenic clusters to myogenic (even at early stages), nor do they express myogenic markers. Further, at least some of these non-myogenic cells gave rise to chondrocytes, which to our knowledge has never been shown to give rise to skeletal muscle. Additionally, bipotency appears to be more associated with myogenic cells since they express <italic>Myf5</italic>, and to a minor extent <italic>Myod</italic>. Finally, we did not observe NCC-derived <italic>Myf5</italic>+ cells indicating that connective tissue in the head does not give rise to muscle. Nevertheless, to formally exclude the possibility of connective tissue progenitors giving rise to muscle in the embryo, analysis of appropriate markers would need to be done (ex. <italic>Pdgfra</italic>-driven lineage). Further studies should provide insights into the evolutionary ancestry of progenitors that bifurcate to give rise to myogenic and connective tissue cells by studying other model organisms that are devoid of neural crest cells.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">B6D2F1/JRj</td><td align="left" valign="bottom">Janvier</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Myf5<sup>Cre</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17418413/">17418413</ext-link></td><td align="left" valign="bottom">MGI:3710099</td><td align="left" valign="bottom">Dr. Mario R Capecchi (Institute of Human Genetics, University of Utah, USA)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Wnt1<sup>Cre</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9843687/">9843687</ext-link></td><td align="left" valign="bottom">MGI:J:69326</td><td align="left" valign="bottom">Pr. Andrew P. McMahon (Keck School of Medicine of the University of Southern California, USA)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Mesp1<sup>Cre</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10393122/">10393122</ext-link></td><td align="left" valign="bottom">MGI:2176467</td><td align="left" valign="bottom">Pr. Yumiko Saga (National Institute of Genetics, Japan)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Myf5<sup>nlacZ</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/8918877">8918877</ext-link></td><td align="left" valign="bottom">MGI:1857973</td><td align="left" valign="bottom">Dr. Shahragim Tajbakhsh (Department of Developmental and Stem Cell Biology, Institut Pasteur, France)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Rosa26<sup>tdTomato</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20023653/">20023653</ext-link></td><td align="left" valign="bottom">MGI:3809524</td><td align="left" valign="bottom">Dr. Hongkui Zeng (Allen Institute for Brain Science, USA)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Rosa26<sup>mT/mG</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17868096">17868096</ext-link></td><td align="left" valign="bottom">MGI:3716464</td><td align="left" valign="bottom">Pr. Philippe Soriano (Icahn School of Medicine at Mt. Sinai, USA)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Pdgfra<sup>H2BGFP</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12748302/">12748302</ext-link></td><td align="left" valign="bottom">MGI:2663656</td><td align="left" valign="bottom">Pr. Philippe Soriano (Icahn School of Medicine at Mt. Sinai, USA)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Myod<sup>iCre</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19464281/">19464281</ext-link></td><td align="left" valign="bottom">MGI:3840216</td><td align="left" valign="bottom">Pr. David Goldhamer (University of Connecticut, USA)</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Myf5<sup>GFP-P</sup></italic></td><td align="left" valign="bottom">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15386014/">15386014</ext-link></td><td align="left" valign="bottom">MGI:3055340</td><td align="left" valign="bottom">Dr. Shahragim Tajbakhsh (Department of Developmental and Stem Cell Biology, Institut Pasteur, France)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Sucrose,for molecular biology, ≥ 99.5% (GC)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">S0389-500G</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Gelatin</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">G-7041</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Foxp2 5C11A8 (Mouse monoclonal)</td><td align="left" valign="bottom">Santa Cruz</td><td align="left" valign="bottom">SC-517261</td><td align="left" valign="bottom">IF (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-gal (Chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat. #: ab9361 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_307210">AB_307210</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-β-gal (Rabbit polyclonal)</td><td align="left" valign="bottom">MP Biomedicals</td><td align="left" valign="bottom">Cat. #: MP 559761 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687418">AB_2687418</ext-link></td><td align="left" valign="bottom">IF (1:1500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (Chicken polyclonal)</td><td align="left" valign="bottom">Aves Labs</td><td align="left" valign="bottom">Cat. #: 1020 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10000240">AB_10000240</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GFP (Chicken polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat. #: 13970 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_300798">AB_300798</ext-link></td><td align="left" valign="bottom">IF (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Myod (Mouse monoclonal)</td><td align="left" valign="bottom">Dako</td><td align="left" valign="bottom">Cat. #: M3512 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2148874">AB_2148874</ext-link></td><td align="left" valign="bottom">IF (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Myod (Mouse monoclonal)</td><td align="left" valign="bottom">BD-Biosciences</td><td align="left" valign="bottom">Cat. #: 554130 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_395255">AB_395255</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Pax7 (Mouse monoclonal)</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">Cat. #: Pax7 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_528428">AB_528428</ext-link></td><td align="left" valign="bottom">IF (1:20)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Myog (Mouse monoclonal)</td><td align="left" valign="bottom">DSHB</td><td align="left" valign="bottom">Cat. #: F5D RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2146602">AB_2146602</ext-link></td><td align="left" valign="bottom">IF (1:20)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 633 F(ab')2 Fragment of Goat Anti-Rabbit IgG (H + L) (polyclonal antibody)</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat. #: A-21072 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535733">AB_2535733</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 555 F(ab')2 Fragment of Goat Anti-Rabbit IgG (H + L) (polyclonal antibody)</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat. #: A-21430 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535851">AB_2535851</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 F(ab')2 Fragment of Goat Anti-Rabbit IgG (H + L) (polyclonal antibody)</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat. #: A-11070 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534114">AB_2534114</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 633 Goat Anti-Chicken IgG (H + L) (polyclonal antibody)</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat. #: A-21103 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535756">AB_2535756</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 Goat Anti-Chicken IgG (H + L) (polyclonal antibody)</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat. #: A-11039 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534096">AB_2534096</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 633 Goat Anti-Mouse IgG1 (γ1) (polyclonal antibody)</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat. #: A-21126 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535768">AB_2535768</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor488 AffiniPure Goat Anti-Mouse IgG1 (γ1) (polyclonal antibody)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat. #: 115-545-205 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2338854">AB_2338854</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy3-AffiniPure Goat Anti-Mouse IgG1 (γ1) (polyclonal antibody)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat. #: 115-165-205 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2338694">AB_2338694</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy3-AffiniPure Goat Anti-Mouse IgG2a (γ2a) (polyclonal antibody)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat. #: 115-165-206 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2338695">AB_2338695</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Dylight 405 Goat Anti-Mouse IgG2a (γ2a) (polyclonal antibody)</td><td align="left" valign="bottom">Jackson ImmunoResearch</td><td align="left" valign="bottom">Cat. #: 115-475-206 RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2338800">AB_2338800</ext-link></td><td align="left" valign="bottom">IF (1:500)</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Hoechst 33,342</td><td align="left" valign="bottom">Thermo Scientific</td><td align="left" valign="bottom">Cat. #:H3570</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope Multiplex Fluorescent reagent Kit-V2</td><td align="left" valign="bottom">ACD/Bio-techne</td><td align="left" valign="bottom">Cat. #: 323100</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope H202 &amp; Protease Plus Reagents</td><td align="left" valign="bottom">ACD/Bio-techne</td><td align="left" valign="bottom">Cat #: 322330</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Opal 650 Reagent Pack</td><td align="left" valign="bottom">PerkinElmer</td><td align="left" valign="bottom">Cat. #: FP1496001KT</td><td align="left" valign="bottom">1:1,500 of reconstituted reagent in RNAscope Multiplex TSA Buffer</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Opal 570 Reagent Pack</td><td align="left" valign="bottom">PerkinElmer</td><td align="left" valign="bottom">Cat. #: FP1488001KT</td><td align="left" valign="bottom">1:1,500 of reconstituted reagent in RNAscope Multiplex TSA Buffer</td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope Mm-Pdgfa</td><td align="left" valign="bottom">Advanced Cell Diagnostics, Inc</td><td align="left" valign="bottom">Cat #:411361</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope Mm-Pdgfra</td><td align="left" valign="bottom">Advanced Cell Diagnostics, Inc</td><td align="left" valign="bottom">Cat #:480661-C2</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope Mm-Bmpr1b</td><td align="left" valign="bottom">Advanced Cell Diagnostics, Inc</td><td align="left" valign="bottom">Cat #:533941</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope Mm-Efnb1</td><td align="left" valign="bottom">Advanced Cell Diagnostics, Inc</td><td align="left" valign="bottom">Cat #:526761</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope Mm-Bmp4-O1-C3</td><td align="left" valign="bottom">Advanced Cell Diagnostics, Inc</td><td align="left" valign="bottom">Cat #:527501-C3</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope Mm-Ephb1-C3</td><td align="left" valign="bottom">Advanced Cell Diagnostics, Inc</td><td align="left" valign="bottom">Cat #:567571-C3</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">RNAscope Mm-Scube1</td><td align="left" valign="bottom">Advanced Cell Diagnostics, Inc</td><td align="left" valign="bottom">Cat #:488131</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Paraformaldehyde</td><td align="left" valign="bottom">Electron Microscopy Sciences</td><td align="left" valign="bottom">Cat. #: 15710</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Isopentane</td><td align="left" valign="bottom">VWR</td><td align="left" valign="bottom">Cat. #: 24872.298</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Triton X-100</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat. #: T8787</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tween 20</td><td align="left" valign="bottom">Sigma</td><td align="left" valign="bottom">Cat. #: P1379</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TrypLE</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">Cat #: 12604013</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Calcein Blue</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat #: 65-0855-39</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Propidium Iodide</td><td align="left" valign="bottom">ThermoFisher</td><td align="left" valign="bottom">Cat #: P1304MP</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Chromium Next GEM Chip G Single Cell Kit, 16 rxns</td><td align="left" valign="bottom">10 X Genomics</td><td align="left" valign="bottom">Cat #: 1000127</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Chromium Next GEM Single Cell 3' GEM, Library &amp; Gel Bead Kit v3.1, 4 rxns</td><td align="left" valign="bottom">10 X Genomics</td><td align="left" valign="bottom">Cat #:1000128</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">NextSeq 500/550 High Output Kit v2.5</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">Cat #: 20024906</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Agilent High Sensitivity DNA Kit</td><td align="left" valign="bottom">Agilent</td><td align="left" valign="bottom">Cat #:5067–4626</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Agilent High Sensitivity DNA Reagents</td><td align="left" valign="bottom">Agilent</td><td align="left" valign="bottom">Cat #:5067–4627</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Commercial assay, kit</td><td align="left" valign="bottom">Qubit dsDNA HS Assay Kit</td><td align="left" valign="bottom">Life Technologies</td><td align="left" valign="bottom">Cat #:Q32854</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RStudio</td><td align="left" valign="bottom">Rstudio</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Anaconda</td><td align="left" valign="bottom">Anaconda Inc</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Zen</td><td align="left" valign="bottom">Zeiss</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Cytoscape</td><td align="left" valign="bottom">Cytoscape Team</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji</td><td align="left" valign="bottom">Johannes Schindelin, Ignacio Arganda-Carreras, Albert Cardona, Mark Longair, Benjamin Schmid, and others</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism</td><td align="left" valign="bottom">GraphPad Software</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom"> </td><td align="left" valign="bottom"> </td></tr></tbody></table></table-wrap><sec id="s4-1"><title>scRNAseq data generation</title><p>For E10.5 to E12.5 embryos, the cranial region above the forelimb was dissected in ice-cold 3% FBS in PBS and mechanically dissociated with forceps and pipetting. The same procedure was applied at E14.5 but the dissection was refined to the pharyngeal and laryngeal regions. Tissues were then digested in TrypLE (ThermoFisher Cat #: 12604013) during 3 rounds of 5 min incubation (37 °C, 1400 RPM), interspersed with gentle pipetting to further dissociate the tissue. Cells were resuspended in FBS 3%, filtered, and incubated with Calcein Blue (eBioscience, Cat #: 65-0855-39) and Propidium Iodide (ThermoFisher Cat #: P1304MP) to check for viability. Viable cells were sorted on BD FACS Aria III and manually counted using a hemocytometer. RNA integrity was assessed with Agilent Bioanalyzer 2,100 to validate the isolation protocol prior to scRNAseq (RIN &gt;8 was considered acceptable). A total of 4000–13,000 cells were loaded onto 10 X Genomics Chromium microfluidic chip and cDNA libraries were generated following manufacturer’s protocol. Concentrations and fragment sizes were measured using Agilent Bioanalyzer and Invitrogen Qubit. cDNA libraries were sequenced using NextSeq 500 and High Output v2.5 (75 cycles) kits. Genome mapping and count matrix generation were done following 10X Genomics Cell Ranger pipeline.</p></sec><sec id="s4-2"><title>RNA velocity and driver genes</title><p>RNA velocity analyses were performed using scvelo (<xref ref-type="bibr" rid="bib6">Bergen et al., 2020</xref>) in Python. This tool allows inferring velocity flow and driver genes using scRNAseq data, with major improvements from previous methods (<xref ref-type="bibr" rid="bib47">La Manno et al., 2018</xref>). First, unspliced and spliced transcript matrices were generated using velocyto (<xref ref-type="bibr" rid="bib47">La Manno et al., 2018</xref>) command line function, which outputs unspliced, spliced, and ambiguous matrices as a single loom file. These files were combined with filtered Seurat objects to yield objects with unspliced and spliced matrices, as well as Seurat-generated annotations and cell-embeddings (UMAP, tSNE, PCA). These datasets were then processed following scvelo online guide and documentation. Velocity was calculated based on the dynamical model (using <italic>scv.tl.recover_dynamics(adata</italic>), and <italic>scv.tl.velocity(adata, mode=’dynamical’</italic>)) and when outliers were detected, differential kinetics based on top driver genes were calculated and added to the model (using <italic>scv.tl.velocity(adata, diff_kinetics = True</italic>)). Specific driver genes were identified by determining the top likelihood genes in the selected cluster. The lists of top 100 drivers for each stage are given in <xref ref-type="table" rid="table1">Table 1</xref>.</p></sec><sec id="s4-3"><title>Data processing</title><p>scRNAseq datasets were preprocessed using Seurat in R (<ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/">https://satijalab.org/seurat/</ext-link>) (<xref ref-type="bibr" rid="bib13">Butler et al., 2018</xref>). Cells with more than 20% of mitochondrial gene fraction were discarded. The number of genes expressed averaged to 4000 in all four datasets. Dimension reduction and UMAP generation were performed following Seurat workflow. Doublets were inferred using DoubletFinder v3 (<xref ref-type="bibr" rid="bib57">McGinnis et al., 2019</xref>). Cell cycle genes, mitochondrial fraction, number of genes, number of UMI were regressed in all datasets following Seurat dedicated vignette. We noticed that cell cycle regression, although clarifying anatomical diversity, seemed to induce low and high UMI clustering (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). For the E10.5 and E11.5 datasets, two replicates were generated from littermates and merged after confirming their similitude. For subsequent datasets (E12.5 and E14.5), no replicates were used. Annotation and subsetting were also performed in Seurat. ‘Myogenic’ and ‘Non-myogenic’ annotations were based on <italic>Pdgfa</italic> and <italic>Pdgfra</italic> expression and myogenic genes <italic>Myf5</italic>, <italic>Myod</italic>, and <italic>Myog</italic>. Cells not expressing <italic>Pdgfa</italic> were annotated as ‘non-myogenic’ unless they express myogenic genes. Cells expressing <italic>Pdgfa</italic> were annotated as ‘myogenic’. We noticed that at later stages, <italic>Pdgfa</italic> expression decreases in Myog+ cells. Driver genes of connective tissue at E12.5 and E14.5 were determined using cluster annotations obtained from Leiden-based clustering. Myogenic and non-myogenic scores were generated by aggregating the total expression of all genes in a signature based on the top 10 markers of these compartments (visible on <xref ref-type="fig" rid="fig4">Figure 4C</xref>). Each score was then divided by the sum of the two to generate myogenic and non-myogenic signatures. The coexpression score was defined by the product of these signatures. To generate the plots, cells were ordered based on their non-myogenic signature. The ‘transition’ was defined as cells with a coexpression score higher than 0.20.</p></sec><sec id="s4-4"><title>Gene regulatory network inference</title><p>Gene regulatory networks were inferred using SCENIC (R implementation) (<xref ref-type="bibr" rid="bib2">Aibar et al., 2017</xref>) and pySCENIC (Python implementation) (<xref ref-type="bibr" rid="bib83">Van de Sande et al., 2020</xref>). This algorithm allows regrouping of sets of correlated genes into regulons (i.e. a transcription factor and its targets) based on motif binding and co-expression. UMAP and heatmap were generated using regulon AUC matrix (Area Under Curve) which refers to the activity level of each regulon in each cell. We used two cisTarget databases: ‘mm9-500bp-upstream-7species.mc9nr’ (500 bp upstream of TSS) and ‘mm9-tss-centered-10kb-7species.mc9nr’ (10kb ±TSS).</p></sec><sec id="s4-5"><title>Driver regulons</title><p>Results from SCENIC and scvelo were combined to identify regulons that could be responsible for the transcriptomic induction of driver genes. Similarly to the steps mentioned above, SCENIC lists of regulons were used to infer connections between transcription factors and driver gene. Networks were generated as explained above and annotated with ‘Active regulon’ or ‘driver gene’. The lists of individual driver regulons of each dataset were then combined and the most recurring driver regulons were identified. The code is available at this address: <ext-link ext-link-type="uri" xlink:href="https://github.com/TajbakhshLab/DriverRegulators">https://github.com/TajbakhshLab/DriverRegulators</ext-link>, (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:8de8228c445b380ce67fd8fb5866a0bcbcd93f3b;origin=https://github.com/TajbakhshLab/DriverRegulators;visit=swh:1:snp:eec9f98b7df6daa821eb336d769afaa6f680803f;anchor=swh:1:rev:49db57e7ede9f248de937b7a47eb96b02aa2ce67">swh:1:rev:49db57e7ede9f248de937b7a47eb96b02aa2ce67</ext-link>; <xref ref-type="bibr" rid="bib33">Grimaldi, 2021</xref>).</p></sec><sec id="s4-6"><title>Gene set enrichment analysis</title><p>Gene set enrichment analyses were performed on either the top markers (obtained from Seurat function FindAllMarkers) or from driver genes (obtained from scvelo), using Cluego (<xref ref-type="bibr" rid="bib9">Bindea et al., 2009</xref>). ‘GO Molecular Pathway’, ‘GO Biological Process’ and ‘Reactome pathways’ were used independently to identify common and unique pathways involved in each dataset. In all analyses, an enrichment/depletion two-sided hypergeometric test was performed and p-values were corrected using the Bonferroni step down method.</p></sec><sec id="s4-7"><title>Mouse strains</title><p>Animals were handled as per European Community guidelines and the ethics committee of the Institut Pasteur (CETEA) approved protocols (APAFIS#6354–20160809 l2028839). The following strains were previously described: <italic>Myf5<sup>Cre </sup></italic>(<xref ref-type="bibr" rid="bib35">Haldar et al., 2008</xref>), <italic>Myod<sup>iCre</sup></italic> (<xref ref-type="bibr" rid="bib41">Kanisicak et al., 2009</xref>), <italic>Mesp1<sup>Cre</sup></italic> (<xref ref-type="bibr" rid="bib69">Saga et al., 1999</xref>), <italic>Tg:Wnt1Cre</italic> (<xref ref-type="bibr" rid="bib20">Danielian et al., 1998</xref>), <italic>Rosa26<sup>TdTom</sup></italic> (Ai9; <xref ref-type="bibr" rid="bib53">Madisen et al., 2010</xref>), <italic>Rosa26<sup>mTmG</sup></italic> (<xref ref-type="bibr" rid="bib59">Muzumdar et al., 2007</xref>), <italic>Myf5<sup>nlacZ</sup></italic> (<xref ref-type="bibr" rid="bib77">Tajbakhsh et al., 1996</xref>), <italic>Pdgfra<sup>H2BGFP</sup></italic> (<xref ref-type="bibr" rid="bib36">Hamilton et al., 2003</xref>) and <italic>Myf5<sup>GFP-P</sup></italic> (<xref ref-type="bibr" rid="bib43">Kassar-Duchossoy et al., 2004</xref>). To generate <italic>Myf5<sup>Cre/+</sup>;Rosa26<sup>TdTomato/+</sup>;Pdgfra<sup>H2BGFP/+</sup></italic>embryos, <italic>Myf5<sup>Cre/+</sup></italic> females were crossed with <italic>Pdgfra<sup>H2BGFP/+</sup>;Rosa26<sup>TdTomato/TdTomato</sup></italic> males. Mice were kept on a mixed genetic background C57BL/6JRj and DBA/2JRj (B6D2F1, Janvier Labs). Mouse embryos and fetuses were collected between embryonic day (E) E10.5 and E14.5, with noon on the day of the vaginal plug considered as E0.5.</p></sec><sec id="s4-8"><title>Immunofluorescence</title><p>Collected embryonic and adult tissues were fixed 2.5 h in 4% paraformaldehyde (Electron Microscopy Sciences, Cat #:15710) in PBS with 0.2–0.5% Triton X-100 (according to their stage) at 4 °C and washed overnight at 4 °C in PBS. In preparation for cryosectioning, embryos were equilibrated in 30% sucrose in PBS overnight at 4 °C and embedded in OCT. Cryosections (16–20 µm) were left to dry at RT for 30 min and washed in PBS. For Foxp2 immunostaining (Santa Cruz Cat. #: SC-517261), embryos were first equilibrated in 15% sucrose overnight, then in a 15% sucrose/7.5% gelatin solution at 37 °C the next day and embedded in the same solution the following day. Blocks were then kept at 4 °C in a humid environment and trimmed, before being submerged in liquid nitrogen-cooled isopentane at –60 °C to freeze. After cryosectioning, slides were washed twice for 15 min each at 37 °C inPBS to remove the gelatin. The primary antibodies used in this study are chicken polyclonal anti-β-gal (Abcam, Cat #: ab9361, dilution 1:1000), mouse monoclonal IgG1 anti-Myod (BD Biosciences, Cat# 554130, dilution 1:100), mouse monoclonal IgG1 anti-Pax7 (DSHB, Cat. #: AB_528428, dilution 1:20), rabbit anti-mouse Sox9 (Millipore, Cat. #: AB5535, dilution 1/2000), rabbit polyclonal anti-Tomato (Clontech Cat. #: 632496, dilution 1:400) and chicken polyclonal anti-GFP (Abcam Cat. #: 13970, dilution 1:1000). Images were acquired using Zeiss LSM780 or LSM700 confocal microscopes and processed using ZEN software (Carl Zeiss). Control and mutant embryos were selected randomly, quantifications were performed blindly by hiding the discriminating channels. Quantifications were performed using Fiji (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/software/fiji/">https://imagej.net/software/fiji/</ext-link>). Barplots, dotplots and boxplots were generated using Seaborn (<ext-link ext-link-type="uri" xlink:href="https://seaborn.pydata.org">https://seaborn.pydata.org</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://seaborn.pydata.org/">https://seaborn.pydata.org/</ext-link>) or Prism (<ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/scientific-software/prism/">https://www.graphpad.com/scientific-software/prism/</ext-link>). For the <italic>Myf5<sup>Cre/+</sup>;Rosa26<sup>TdTomato/+</sup>;Pdgfra<sup>H2BGFP/+</sup></italic> embryos, 4 regions were manually defined across the medio-lateral axis. For each region, the absolute number of double-positive cells within the defined area was divided by the total number of GFP+ cells which was determined first, and blindly (with the TOMchannel disabled). For the <italic>Myod<sup>iCre</sup></italic> lineage-tracing experiment, the absolute number of double positive cells were counted and divided by the area of the muscle given by the TOM channel. These ‘number of cells/area’ scores were then corrected based on the size of the image in microns, and adjusted to match an area of 100 μm<sup>2</sup> of muscle. To quantify the intensity of Foxp2 immunostaining, we first generated ROIs of the <italic>Myf5</italic>-derived cells based on the TOM channels as previously mentioned and extracted the mean pixel value. All images were acquired using the exact same settings for a given embryo.</p></sec><sec id="s4-9"><title>RNAscope in situ hybridization</title><p>Embryos for in situ hybridization were fixed overnight in 4% PFA. Embryos were equilibrated in 30% sucrose in PBS and sectioned as described for immunofluorescence. RNAscope probes Mm-Pdgfa (411361), Mm-Pdgfra (480661-C2), Mm-Bmpr1b (533941), Mm-Efnb1 (526761), Mm-Bmp4-O1-C3 (527501-C3), Mm-Ephb1-C3 (567571-C3) and Mm-Scube1 (488131) were purchased from Advanced Cell Diagnostics, Inc. In situ hybridization was performed using the RNAscope Multiplex Fluorescent Reagent Kit V2 as described previously (<xref ref-type="bibr" rid="bib16">Comai et al., 2019</xref>). Quantifications were performed using Fiji (<ext-link ext-link-type="uri" xlink:href="https://imagej.net/software/fiji/">https://imagej.net/software/fiji/</ext-link>). 2 ROIs were first defined visually using the GFP channel: ‘myogenic’ and ‘non-myogenic’. The channels containing the RNAscope signals were then thresholded to obtain binary images, and measurement of the ‘Area%’ was performed for each ROI. For each probe, we generated a ratio of myogenic to non-myogenic signal. The ratio of each receptor was then substracted from the ratio of each corresponding ligand.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf3"><p>Reviewing editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Validation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animals were handled as per European Community guidelines and the ethics committee of the Institut Pasteur (CETEA) approved protocols (APAFIS#6354-20160809 l2028839).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-70235-transrepform1-v3.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>scRNAseq datasets are available in open access on DRYAD at the following address: <ext-link ext-link-type="uri" xlink:href="https://datadryad.org/stash/dataset/doi:10.5061/dryad.gf1vhhmrs?">https://datadryad.org/stash/dataset/doi:10.5061/dryad.gf1vhhmrs?</ext-link>. The code that was used to generate the driver regulators is available at this address: <ext-link ext-link-type="uri" xlink:href="https://github.com/TajbakhshLab/DriverRegulators">https://github.com/TajbakhshLab/DriverRegulators</ext-link>, (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:8de8228c445b380ce67fd8fb5866a0bcbcd93f3b;origin=https://github.com/TajbakhshLab/DriverRegulators;visit=swh:1:snp:eec9f98b7df6daa821eb336d769afaa6f680803f;anchor=swh:1:rev:49db57e7ede9f248de937b7a47eb96b02aa2ce67">swh:1:rev:49db57e7ede9f248de937b7a47eb96b02aa2ce67</ext-link>). Source data files have been provided for Figure 3J, Figure 4H, Figure 5F, Figure 5J, Figure 5-figure supplement 1E, Figure 7E and Figure 7G.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Grimaldi</surname><given-names>A</given-names></name><name><surname>Mella</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>scRNAseq_raw_filtered_preprocessed</data-title><source>Dryad Digital Repository</source><pub-id pub-id-type="doi">10.5061/dryad.gf1vhhmrs</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We acknowledge funding support from the Institut Pasteur, Association Française contre le Myopathies, Agence Nationale de la Recherche (Laboratoire d’Excellence Revive, Investissement d’Avenir; ANR-10-LABX-73) and MyoHead (ANR-19-CE13-0008-01), Association Française contre les Myopathies (Grant #20510), Fondation pour la Recherche Médicale (Grant # FDT201904008277), and the Centre National de la Recherche Scientifique. We gratefully acknowledge the UtechS Photonic BioImaging, C2RT, Institut Pasteur, supported by the French National Research Agency (France BioImaging; ANR-10–INSB–04; Investments for the Future).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>N</given-names></name><name><surname>Bilio</surname><given-names>M</given-names></name><name><surname>Baldini</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cardiopharyngeal mesoderm origins of musculoskeletal and connective tissues in the mammalian pharynx</article-title><source>Development (Cambridge, England)</source><volume>147</volume><elocation-id>dev185256</elocation-id><pub-id pub-id-type="doi">10.1242/dev.185256</pub-id><pub-id pub-id-type="pmid">32014863</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>González-Blas</surname><given-names>CB</given-names></name><name><surname>Moerman</surname><given-names>T</given-names></name><name><surname>Huynh-Thu</surname><given-names>VA</given-names></name><name><surname>Imrichova</surname><given-names>H</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Rambow</surname><given-names>F</given-names></name><name><surname>Marine</surname><given-names>J-C</given-names></name><name><surname>Geurts</surname><given-names>P</given-names></name><name><surname>Aerts</surname><given-names>J</given-names></name><name><surname>van den Oord</surname><given-names>J</given-names></name><name><surname>Atak</surname><given-names>ZK</given-names></name><name><surname>Wouters</surname><given-names>J</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SCENIC: single-cell regulatory network inference and clustering</article-title><source>Nature Methods</source><volume>14</volume><fpage>1083</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4463</pub-id><pub-id pub-id-type="pmid">28991892</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>LL</given-names></name><name><surname>Cecchini</surname><given-names>A</given-names></name><name><surname>Stark</surname><given-names>DA</given-names></name><name><surname>Ihnat</surname><given-names>J</given-names></name><name><surname>Craigg</surname><given-names>RN</given-names></name><name><surname>Carter</surname><given-names>A</given-names></name><name><surname>Zino</surname><given-names>S</given-names></name><name><surname>Cornelison</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>EphA7 promotes myogenic differentiation via cell-cell contact</article-title><source>eLife</source><volume>9</volume><elocation-id>e53689</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.53689</pub-id><pub-id pub-id-type="pmid">32314958</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babb</surname><given-names>R</given-names></name><name><surname>Chandrasekaran</surname><given-names>D</given-names></name><name><surname>Carvalho Moreno Neves</surname><given-names>V</given-names></name><name><surname>Sharpe</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Axin2-expressing cells differentiate into reparative odontoblasts via autocrine Wnt/β-catenin signaling in response to tooth damage</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>3102</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-03145-6</pub-id><pub-id pub-id-type="pmid">28596530</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Yair</surname><given-names>R</given-names></name><name><surname>Kalcheim</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Notch and bone morphogenetic protein differentially act on dermomyotome cells to generate endothelium, smooth, and striated muscle</article-title><source>The Journal of Cell Biology</source><volume>180</volume><fpage>607</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1083/jcb.200707206</pub-id><pub-id pub-id-type="pmid">18268106</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergen</surname><given-names>V</given-names></name><name><surname>Lange</surname><given-names>M</given-names></name><name><surname>Peidli</surname><given-names>S</given-names></name><name><surname>Wolf</surname><given-names>FA</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Generalizing RNA velocity to transient cell states through dynamical modeling</article-title><source>Nature Biotechnology</source><volume>38</volume><fpage>1408</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1038/s41587-020-0591-3</pub-id><pub-id pub-id-type="pmid">32747759</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biferali</surname><given-names>B</given-names></name><name><surname>Proietti</surname><given-names>D</given-names></name><name><surname>Mozzetta</surname><given-names>C</given-names></name><name><surname>Madaro</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Fibro-Adipogenic Progenitors Cross-Talk in Skeletal Muscle: The Social Network</article-title><source>Frontiers in Physiology</source><volume>10</volume><elocation-id>1074</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2019.01074</pub-id><pub-id pub-id-type="pmid">31496956</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bildsoe</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Wilkie</surname><given-names>EE</given-names></name><name><surname>Ashoti</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>VJ</given-names></name><name><surname>Power</surname><given-names>M</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Tam</surname><given-names>PPL</given-names></name><name><surname>Loebel</surname><given-names>DAF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Transcriptional targets of TWIST1 in the cranial mesoderm regulate cell-matrix interactions and mesenchyme maintenance</article-title><source>Developmental Biology</source><volume>418</volume><fpage>189</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2016.08.016</pub-id><pub-id pub-id-type="pmid">27546376</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindea</surname><given-names>G</given-names></name><name><surname>Mlecnik</surname><given-names>B</given-names></name><name><surname>Hackl</surname><given-names>H</given-names></name><name><surname>Charoentong</surname><given-names>P</given-names></name><name><surname>Tosolini</surname><given-names>M</given-names></name><name><surname>Kirilovsky</surname><given-names>A</given-names></name><name><surname>Fridman</surname><given-names>WH</given-names></name><name><surname>Pagès</surname><given-names>F</given-names></name><name><surname>Trajanoski</surname><given-names>Z</given-names></name><name><surname>Galon</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks</article-title><source>Bioinformatics (Oxford, England)</source><volume>25</volume><fpage>1091</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp101</pub-id><pub-id pub-id-type="pmid">19237447</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bothe</surname><given-names>I</given-names></name><name><surname>Dietrich</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The molecular setup of the avian head mesoderm and its implication for craniofacial myogenesis</article-title><source>Developmental Dynamics</source><volume>235</volume><fpage>2845</fpage><lpage>2860</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20903</pub-id><pub-id pub-id-type="pmid">16894604</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckingham</surname><given-names>M</given-names></name><name><surname>Rigby</surname><given-names>PWJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gene regulatory networks and transcriptional mechanisms that control myogenesis</article-title><source>Developmental Cell</source><volume>28</volume><fpage>225</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.12.020</pub-id><pub-id pub-id-type="pmid">24525185</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>AC</given-names></name><name><surname>Nowicki</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A new view of patterning domains in the vertebrate mesoderm</article-title><source>Developmental Cell</source><volume>4</volume><fpage>159</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1016/s1534-5807(03)00033-9</pub-id><pub-id pub-id-type="pmid">12586060</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Spielmann</surname><given-names>M</given-names></name><name><surname>Qiu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Ibrahim</surname><given-names>DM</given-names></name><name><surname>Hill</surname><given-names>AJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Mundlos</surname><given-names>S</given-names></name><name><surname>Christiansen</surname><given-names>L</given-names></name><name><surname>Steemers</surname><given-names>FJ</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The single-cell transcriptional landscape of mammalian organogenesis</article-title><source>Nature</source><volume>566</volume><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-0969-x</pub-id><pub-id pub-id-type="pmid">30787437</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christ</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Scaal</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Amniote somite derivatives</article-title><source>Developmental Dynamics</source><volume>236</volume><fpage>2382</fpage><lpage>2396</lpage><pub-id pub-id-type="doi">10.1002/dvdy.21189</pub-id><pub-id pub-id-type="pmid">17557304</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comai</surname><given-names>G</given-names></name><name><surname>Heude</surname><given-names>E</given-names></name><name><surname>Mella</surname><given-names>S</given-names></name><name><surname>Paisant</surname><given-names>S</given-names></name><name><surname>Pala</surname><given-names>F</given-names></name><name><surname>Gallardo</surname><given-names>M</given-names></name><name><surname>Langa</surname><given-names>F</given-names></name><name><surname>Kardon</surname><given-names>G</given-names></name><name><surname>Gopalakrishnan</surname><given-names>S</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A distinct cardiopharyngeal mesoderm genetic hierarchy establishes antero-posterior patterning of esophagus striated muscle</article-title><source>eLife</source><volume>8</volume><elocation-id>e47460</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.47460</pub-id><pub-id pub-id-type="pmid">31535973</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comai</surname><given-names>GE</given-names></name><name><surname>Tesařová</surname><given-names>M</given-names></name><name><surname>Dupé</surname><given-names>V</given-names></name><name><surname>Rhinn</surname><given-names>M</given-names></name><name><surname>Vallecillo-García</surname><given-names>P</given-names></name><name><surname>da Silva</surname><given-names>F</given-names></name><name><surname>Feret</surname><given-names>B</given-names></name><name><surname>Exelby</surname><given-names>K</given-names></name><name><surname>Dollé</surname><given-names>P</given-names></name><name><surname>Carlsson</surname><given-names>L</given-names></name><name><surname>Pryce</surname><given-names>B</given-names></name><name><surname>Spitz</surname><given-names>F</given-names></name><name><surname>Stricker</surname><given-names>S</given-names></name><name><surname>Zikmund</surname><given-names>T</given-names></name><name><surname>Kaiser</surname><given-names>J</given-names></name><name><surname>Briscoe</surname><given-names>J</given-names></name><name><surname>Schedl</surname><given-names>A</given-names></name><name><surname>Ghyselinck</surname><given-names>NB</given-names></name><name><surname>Schweitzer</surname><given-names>R</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Local retinoic acid signaling directs emergence of the extraocular muscle functional unit</article-title><source>PLOS Biology</source><volume>18</volume><elocation-id>e3000902</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000902</pub-id><pub-id pub-id-type="pmid">33201874</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conerly</surname><given-names>ML</given-names></name><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>JW</given-names></name><name><surname>Groudine</surname><given-names>M</given-names></name><name><surname>Tapscott</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Distinct Activities of Myf5 and MyoD Indicate Separate Roles in Skeletal Muscle Lineage Specification and Differentiation</article-title><source>Developmental Cell</source><volume>36</volume><fpage>375</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.01.021</pub-id><pub-id pub-id-type="pmid">26906734</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossu</surname><given-names>G</given-names></name><name><surname>Angelis</surname><given-names>LD</given-names></name><name><surname>Borello</surname><given-names>U</given-names></name><name><surname>Berarducci</surname><given-names>B</given-names></name><name><surname>Buffa</surname><given-names>V</given-names></name><name><surname>Sonnino</surname><given-names>C</given-names></name><name><surname>Coletta</surname><given-names>M</given-names></name><name><surname>Vivarelli</surname><given-names>E</given-names></name><name><surname>Bouche</surname><given-names>M</given-names></name><name><surname>Lattanzi</surname><given-names>L</given-names></name><name><surname>Tosoni</surname><given-names>D</given-names></name><name><surname>Donna</surname><given-names>SD</given-names></name><name><surname>Berghella</surname><given-names>L</given-names></name><name><surname>Salvatori</surname><given-names>G</given-names></name><name><surname>Murphy</surname><given-names>P</given-names></name><name><surname>Angelis</surname><given-names>M</given-names></name><name><surname>Molinaro</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Determination, diversification and multipotency of mammalian myogenic cells</article-title><source>Int J Dev Biology</source><volume>44</volume><fpage>699</fpage><lpage>706</lpage></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danielian</surname><given-names>PS</given-names></name><name><surname>Muccino</surname><given-names>D</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name><name><surname>Michael</surname><given-names>SK</given-names></name><name><surname>McMahon</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase</article-title><source>Current Biology</source><volume>8</volume><fpage>1323</fpage><lpage>1326</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(07)00562-3</pub-id><pub-id pub-id-type="pmid">9843687</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daubas</surname><given-names>P</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name><name><surname>Hadchouel</surname><given-names>J</given-names></name><name><surname>Primig</surname><given-names>M</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Myf5 is a novel early axonal marker in the mouse brain and is subjected to post-transcriptional regulation in neurons</article-title><source>Development</source><volume>127</volume><fpage>319</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1242/dev.127.2.319</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Micheli</surname><given-names>AJ</given-names></name><name><surname>Swanson</surname><given-names>JB</given-names></name><name><surname>Disser</surname><given-names>NP</given-names></name><name><surname>Martinez</surname><given-names>LM</given-names></name><name><surname>Walker</surname><given-names>NR</given-names></name><name><surname>Oliver</surname><given-names>DJ</given-names></name><name><surname>Cosgrove</surname><given-names>BD</given-names></name><name><surname>Mendias</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell transcriptomic analysis identifies extensive heterogeneity in the cellular composition of mouse Achilles tendons</article-title><source>American Journal of Physiology. Cell Physiology</source><volume>319</volume><fpage>C885</fpage><lpage>C894</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00372.2020</pub-id><pub-id pub-id-type="pmid">32877217</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devotta</surname><given-names>A</given-names></name><name><surname>Hong</surname><given-names>CS</given-names></name><name><surname>Saint-Jeannet</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Dkk2 promotes neural crest specification by activating Wnt/β-catenin signaling in a GSK3β independent manner</article-title><source>eLife</source><volume>7</volume><elocation-id>e34404</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.34404</pub-id><pub-id pub-id-type="pmid">30035713</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diogo</surname><given-names>R</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Christiaen</surname><given-names>L</given-names></name><name><surname>Levine</surname><given-names>M</given-names></name><name><surname>Ziermann</surname><given-names>JM</given-names></name><name><surname>Molnar</surname><given-names>JL</given-names></name><name><surname>Noden</surname><given-names>DM</given-names></name><name><surname>Tzahor</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A new heart for A new head in vertebrate cardiopharyngeal evolution</article-title><source>Nature</source><volume>520</volume><fpage>466</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1038/nature14435</pub-id><pub-id pub-id-type="pmid">25903628</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durland</surname><given-names>JL</given-names></name><name><surname>Sferlazzo</surname><given-names>M</given-names></name><name><surname>Logan</surname><given-names>M</given-names></name><name><surname>Burke</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Visualizing the lateral somitic frontier in the Prx1Cre transgenic mouse</article-title><source>Journal of Anatomy</source><volume>212</volume><fpage>590</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7580.2008.00879.x</pub-id><pub-id pub-id-type="pmid">18430087</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteves de Lima</surname><given-names>J</given-names></name><name><surname>Blavet</surname><given-names>C</given-names></name><name><surname>Bonnin</surname><given-names>MA</given-names></name><name><surname>Hirsinger</surname><given-names>E</given-names></name><name><surname>Comai</surname><given-names>G</given-names></name><name><surname>Yvernogeau</surname><given-names>L</given-names></name><name><surname>Delfini</surname><given-names>MC</given-names></name><name><surname>Bellenger</surname><given-names>L</given-names></name><name><surname>Mella</surname><given-names>S</given-names></name><name><surname>Nassari</surname><given-names>S</given-names></name><name><surname>Robin</surname><given-names>C</given-names></name><name><surname>Schweitzer</surname><given-names>R</given-names></name><name><surname>Fournier-Thibault</surname><given-names>C</given-names></name><name><surname>Jaffredo</surname><given-names>T</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Duprez</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Unexpected contribution of fibroblasts to muscle lineage as a mechanism for limb muscle patterning</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>3851</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-24157-x</pub-id><pub-id pub-id-type="pmid">34158501</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farahani</surname><given-names>RM</given-names></name><name><surname>Xaymardan</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Platelet-Derived Growth Factor Receptor Alpha as a Marker of Mesenchymal Stem Cells in Development and Stem Cell Biology</article-title><source>Stem Cells International</source><volume>2015</volume><elocation-id>362753</elocation-id><pub-id pub-id-type="doi">10.1155/2015/362753</pub-id><pub-id pub-id-type="pmid">26257789</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferdous</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Abedin</surname><given-names>MJ</given-names></name><name><surname>Jiang</surname><given-names>N</given-names></name><name><surname>Perry</surname><given-names>CE</given-names></name><name><surname>Evers</surname><given-names>BM</given-names></name><name><surname>Gillette</surname><given-names>TG</given-names></name><name><surname>Kyba</surname><given-names>M</given-names></name><name><surname>Trojanowska</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fli1 Promotes Vascular Morphogenesis by Regulating Endothelial Potential of Multipotent Myogenic Progenitors</article-title><source>Circulation Research</source><volume>129</volume><fpage>949</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.318986</pub-id><pub-id pub-id-type="pmid">34544261</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franco</surname><given-names>H</given-names></name><name><surname>Casasnovas</surname><given-names>JJ</given-names></name><name><surname>Cadilla</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Periostin gene expression is regulated by the bHLH transcription factor TWIST2 in human skin fibroblasts</article-title><source>The FASEB Journal</source><volume>23</volume><elocation-id>660</elocation-id><pub-id pub-id-type="doi">10.1096/fasebj.23.1_supplement.660.11</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gans</surname><given-names>C</given-names></name><name><surname>Northcutt</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Neural crest and the origin of vertebrates: A new head</article-title><source>Science (New York, N.Y.)</source><volume>220</volume><fpage>268</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1126/science.220.4594.268</pub-id><pub-id pub-id-type="pmid">17732898</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grenier</surname><given-names>J</given-names></name><name><surname>Teillet</surname><given-names>MA</given-names></name><name><surname>Grifone</surname><given-names>R</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Duprez</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Relationship between neural crest cells and cranial mesoderm during head muscle development</article-title><source>PLOS ONE</source><volume>4</volume><elocation-id>e4381</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0004381</pub-id><pub-id pub-id-type="pmid">19198652</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grimaldi</surname><given-names>A</given-names></name><name><surname>Parada</surname><given-names>C</given-names></name><name><surname>Chai</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A Comprehensive Study of Soft Palate Development in Mice</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0145018</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0145018</pub-id><pub-id pub-id-type="pmid">26671681</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Grimaldi</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>TajbakhshLab/DriverRegulators</data-title><version designator="swh:1:rev:49db57e7ede9f248de937b7a47eb96b02aa2ce67">swh:1:rev:49db57e7ede9f248de937b7a47eb96b02aa2ce67</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:8de8228c445b380ce67fd8fb5866a0bcbcd93f3b;origin=https://github.com/TajbakhshLab/DriverRegulators;visit=swh:1:snp:eec9f98b7df6daa821eb336d769afaa6f680803f;anchor=swh:1:rev:49db57e7ede9f248de937b7a47eb96b02aa2ce67">https://archive.softwareheritage.org/swh:1:dir:8de8228c445b380ce67fd8fb5866a0bcbcd93f3b;origin=https://github.com/TajbakhshLab/DriverRegulators;visit=swh:1:snp:eec9f98b7df6daa821eb336d769afaa6f680803f;anchor=swh:1:rev:49db57e7ede9f248de937b7a47eb96b02aa2ce67</ext-link></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>MK</given-names></name><name><surname>Moran-Rivard</surname><given-names>L</given-names></name><name><surname>Velasquez</surname><given-names>T</given-names></name><name><surname>Nakatsu</surname><given-names>MN</given-names></name><name><surname>Jagla</surname><given-names>K</given-names></name><name><surname>Goulding</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Lbx1 is required for muscle precursor migration along a lateral pathway into the limb</article-title><source>Development (Cambridge, England)</source><volume>127</volume><fpage>413</fpage><lpage>424</lpage><pub-id pub-id-type="doi">10.1242/dev.127.2.413</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldar</surname><given-names>M</given-names></name><name><surname>Karan</surname><given-names>G</given-names></name><name><surname>Tvrdik</surname><given-names>P</given-names></name><name><surname>Capecchi</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Two cell lineages, myf5 and myf5-independent, participate in mouse skeletal myogenesis</article-title><source>Developmental Cell</source><volume>14</volume><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2008.01.002</pub-id><pub-id pub-id-type="pmid">18331721</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>TG</given-names></name><name><surname>Klinghoffer</surname><given-names>RA</given-names></name><name><surname>Corrin</surname><given-names>PD</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms</article-title><source>Molecular and Cellular Biology</source><volume>23</volume><fpage>4013</fpage><lpage>4025</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.11.4013-4025.2003</pub-id><pub-id pub-id-type="pmid">12748302</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>BA</given-names></name><name><surname>Trout</surname><given-names>D</given-names></name><name><surname>Marinov</surname><given-names>GK</given-names></name><name><surname>Amrhein</surname><given-names>H</given-names></name><name><surname>Berghella</surname><given-names>L</given-names></name><name><surname>Goh</surname><given-names>ST</given-names></name><name><surname>Plajzer-Frick</surname><given-names>I</given-names></name><name><surname>Afzal</surname><given-names>V</given-names></name><name><surname>Pennacchio</surname><given-names>LA</given-names></name><name><surname>Dickel</surname><given-names>DE</given-names></name><name><surname>Visel</surname><given-names>A</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Hardison</surname><given-names>RC</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wold</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The changing mouse embryo transcriptome at whole tissue and single-cell resolution</article-title><source>Nature</source><volume>583</volume><fpage>760</fpage><lpage>767</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2536-x</pub-id><pub-id pub-id-type="pmid">32728245</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heude</surname><given-names>E</given-names></name><name><surname>Tesarova</surname><given-names>M</given-names></name><name><surname>Sefton</surname><given-names>EM</given-names></name><name><surname>Jullian</surname><given-names>E</given-names></name><name><surname>Adachi</surname><given-names>N</given-names></name><name><surname>Grimaldi</surname><given-names>A</given-names></name><name><surname>Zikmund</surname><given-names>T</given-names></name><name><surname>Kaiser</surname><given-names>J</given-names></name><name><surname>Kardon</surname><given-names>G</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Unique morphogenetic signatures define mammalian neck muscles and associated connective tissues</article-title><source>eLife</source><volume>7</volume><elocation-id>eLife7</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.40179</pub-id><pub-id pub-id-type="pmid">30451684</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez</surname><given-names>MA</given-names></name><name><surname>Akerblad</surname><given-names>P</given-names></name><name><surname>Sigvardsson</surname><given-names>M</given-names></name><name><surname>Rosen</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade</article-title><source>Molecular and Cellular Biology</source><volume>27</volume><fpage>743</fpage><lpage>757</lpage><pub-id pub-id-type="doi">10.1128/MCB.01557-06</pub-id><pub-id pub-id-type="pmid">17060461</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kameneva</surname><given-names>P</given-names></name><name><surname>Artemov</surname><given-names>AV</given-names></name><name><surname>Kastriti</surname><given-names>ME</given-names></name><name><surname>Faure</surname><given-names>L</given-names></name><name><surname>Olsen</surname><given-names>TK</given-names></name><name><surname>Otte</surname><given-names>J</given-names></name><name><surname>Erickson</surname><given-names>A</given-names></name><name><surname>Semsch</surname><given-names>B</given-names></name><name><surname>Andersson</surname><given-names>ER</given-names></name><name><surname>Ratz</surname><given-names>M</given-names></name><name><surname>Frisén</surname><given-names>J</given-names></name><name><surname>Tischler</surname><given-names>AS</given-names></name><name><surname>de Krijger</surname><given-names>RR</given-names></name><name><surname>Bouderlique</surname><given-names>T</given-names></name><name><surname>Akkuratova</surname><given-names>N</given-names></name><name><surname>Vorontsova</surname><given-names>M</given-names></name><name><surname>Gusev</surname><given-names>O</given-names></name><name><surname>Fried</surname><given-names>K</given-names></name><name><surname>Sundström</surname><given-names>E</given-names></name><name><surname>Mei</surname><given-names>S</given-names></name><name><surname>Kogner</surname><given-names>P</given-names></name><name><surname>Baryawno</surname><given-names>N</given-names></name><name><surname>Kharchenko</surname><given-names>PV</given-names></name><name><surname>Adameyko</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin</article-title><source>Nature Genetics</source><volume>53</volume><fpage>694</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1038/s41588-021-00818-x</pub-id><pub-id pub-id-type="pmid">33833454</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanisicak</surname><given-names>O</given-names></name><name><surname>Mendez</surname><given-names>JJ</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Goldhamer</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Progenitors of skeletal muscle satellite cells express the muscle determination gene, MyoD</article-title><source>Developmental Biology</source><volume>332</volume><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2009.05.554</pub-id><pub-id pub-id-type="pmid">19464281</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kardon</surname><given-names>G</given-names></name><name><surname>Harfe</surname><given-names>BD</given-names></name><name><surname>Tabin</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A Tcf4-positive mesodermal population provides A prepattern for vertebrate limb muscle patterning</article-title><source>Developmental Cell</source><volume>5</volume><fpage>937</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1016/s1534-5807(03)00360-5</pub-id><pub-id pub-id-type="pmid">14667415</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassar-Duchossoy</surname><given-names>L</given-names></name><name><surname>Gayraud-Morel</surname><given-names>B</given-names></name><name><surname>Gomès</surname><given-names>D</given-names></name><name><surname>Rocancourt</surname><given-names>D</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name><name><surname>Shinin</surname><given-names>V</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice</article-title><source>Nature</source><volume>431</volume><fpage>466</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1038/nature02876</pub-id><pub-id pub-id-type="pmid">15386014</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>RD</given-names></name><name><surname>Mebus</surname><given-names>K</given-names></name><name><surname>Roehl</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mandibular arch muscle identity is regulated by a conserved molecular process during vertebrate development</article-title><source>Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution</source><volume>310</volume><fpage>355</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1002/jez.b.21215</pub-id><pub-id pub-id-type="pmid">18338789</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knight</surname><given-names>JD</given-names></name><name><surname>Kothary</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis</article-title><source>Skeletal Muscle</source><volume>1</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/2044-5040-1-29</pub-id><pub-id pub-id-type="pmid">21902831</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>S</given-names></name><name><surname>Adachi</surname><given-names>N</given-names></name><name><surname>Kusakabe</surname><given-names>R</given-names></name><name><surname>Kuratani</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Developmental fates of shark head cavities reveal mesodermal contributions to tendon progenitor cells in extraocular muscles</article-title><source>Zoological Letters</source><volume>7</volume><elocation-id>e3</elocation-id><pub-id pub-id-type="doi">10.1186/s40851-021-00170-2</pub-id><pub-id pub-id-type="pmid">33588955</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Manno</surname><given-names>G</given-names></name><name><surname>Soldatov</surname><given-names>R</given-names></name><name><surname>Zeisel</surname><given-names>A</given-names></name><name><surname>Braun</surname><given-names>E</given-names></name><name><surname>Hochgerner</surname><given-names>H</given-names></name><name><surname>Petukhov</surname><given-names>V</given-names></name><name><surname>Lidschreiber</surname><given-names>K</given-names></name><name><surname>Kastriti</surname><given-names>ME</given-names></name><name><surname>Lönnerberg</surname><given-names>P</given-names></name><name><surname>Furlan</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Borm</surname><given-names>LE</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>van Bruggen</surname><given-names>D</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Barker</surname><given-names>R</given-names></name><name><surname>Sundström</surname><given-names>E</given-names></name><name><surname>Castelo-Branco</surname><given-names>G</given-names></name><name><surname>Cramer</surname><given-names>P</given-names></name><name><surname>Adameyko</surname><given-names>I</given-names></name><name><surname>Linnarsson</surname><given-names>S</given-names></name><name><surname>Kharchenko</surname><given-names>PV</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA velocity of single cells</article-title><source>Nature</source><volume>560</volume><fpage>494</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0414-6</pub-id><pub-id pub-id-type="pmid">30089906</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagha</surname><given-names>M</given-names></name><name><surname>Brunelli</surname><given-names>S</given-names></name><name><surname>Messina</surname><given-names>G</given-names></name><name><surname>Cumano</surname><given-names>A</given-names></name><name><surname>Kume</surname><given-names>T</given-names></name><name><surname>Relaix</surname><given-names>F</given-names></name><name><surname>Buckingham</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Pax3:Foxc2 reciprocal repression in the somite modulates muscular versus vascular cell fate choice in multipotent progenitors</article-title><source>Developmental Cell</source><volume>17</volume><fpage>892</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.10.021</pub-id><pub-id pub-id-type="pmid">20059958</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Le Douarin</surname><given-names>N</given-names></name><name><surname>Kalcheim</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1999">1999</year><source>Developmental and Cell Biology Series</source><publisher-name>Cambridge University Press</publisher-name><pub-id pub-id-type="doi">10.1017/CBO9780511897948</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leavitt</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>MS</given-names></name><name><surname>Borrelli</surname><given-names>MR</given-names></name><name><surname>Januszyk</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>JT</given-names></name><name><surname>Ransom</surname><given-names>RC</given-names></name><name><surname>Mascharak</surname><given-names>S</given-names></name><name><surname>desJardins-Park</surname><given-names>HE</given-names></name><name><surname>Litzenburger</surname><given-names>UM</given-names></name><name><surname>Walmsley</surname><given-names>GG</given-names></name><name><surname>Marshall</surname><given-names>CD</given-names></name><name><surname>Moore</surname><given-names>AL</given-names></name><name><surname>Duoto</surname><given-names>B</given-names></name><name><surname>Adem</surname><given-names>S</given-names></name><name><surname>Foster</surname><given-names>DS</given-names></name><name><surname>Salhotra</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>AH</given-names></name><name><surname>Griffin</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>EZ</given-names></name><name><surname>Barnes</surname><given-names>LA</given-names></name><name><surname>Zielins</surname><given-names>ER</given-names></name><name><surname>Maan</surname><given-names>ZN</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Chan</surname><given-names>CKF</given-names></name><name><surname>Wan</surname><given-names>DC</given-names></name><name><surname>Lorenz</surname><given-names>HP</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Gurtner</surname><given-names>GC</given-names></name><name><surname>Longaker</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prrx1 Fibroblasts Represent a Pro-fibrotic Lineage in the Mouse Ventral Dermis</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108356</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108356</pub-id><pub-id pub-id-type="pmid">33176144</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>WJ</given-names></name><name><surname>Tsao</surname><given-names>KC</given-names></name><name><surname>Yang</surname><given-names>RB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Electrostatics and N-glycan-mediated membrane tethering of SCUBE1 is critical for promoting bone morphogenetic protein signalling</article-title><source>The Biochemical Journal</source><volume>473</volume><fpage>661</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1042/BJ20151041</pub-id><pub-id pub-id-type="pmid">26699903</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>López-Delgado</surname><given-names>AC</given-names></name><name><surname>Delgado</surname><given-names>I</given-names></name><name><surname>Cadenas</surname><given-names>V</given-names></name><name><surname>Sánchez-Cabo</surname><given-names>F</given-names></name><name><surname>Torres</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Axial Skeleton Anterior-Posterior Patterning Is Regulated through Feedback Regulation between Meis Transcription Factors and Retinoic Acid</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.03.09.983106</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname><given-names>L</given-names></name><name><surname>Zwingman</surname><given-names>TA</given-names></name><name><surname>Sunkin</surname><given-names>SM</given-names></name><name><surname>Oh</surname><given-names>SW</given-names></name><name><surname>Zariwala</surname><given-names>HA</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Ng</surname><given-names>LL</given-names></name><name><surname>Palmiter</surname><given-names>RD</given-names></name><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Lein</surname><given-names>ES</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>SJ</given-names></name><name><surname>Hansen</surname><given-names>JM</given-names></name><name><surname>Merrell</surname><given-names>AJ</given-names></name><name><surname>Murphy</surname><given-names>MM</given-names></name><name><surname>Lawson</surname><given-names>JA</given-names></name><name><surname>Hutcheson</surname><given-names>DA</given-names></name><name><surname>Hansen</surname><given-names>MS</given-names></name><name><surname>Angus-Hill</surname><given-names>M</given-names></name><name><surname>Kardon</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Connective tissue fibroblasts and Tcf4 regulate myogenesis</article-title><source>Development (Cambridge, England)</source><volume>138</volume><fpage>371</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1242/dev.057463</pub-id><pub-id pub-id-type="pmid">21177349</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayeuf-Louchart</surname><given-names>A</given-names></name><name><surname>Montarras</surname><given-names>D</given-names></name><name><surname>Bodin</surname><given-names>C</given-names></name><name><surname>Kume</surname><given-names>T</given-names></name><name><surname>Vincent</surname><given-names>SD</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endothelial cell specification in the somite is compromised in Pax3-positive progenitors of Foxc1/2 conditional mutants, with loss of forelimb myogenesis</article-title><source>Development (Cambridge, England)</source><volume>143</volume><fpage>872</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1242/dev.128017</pub-id><pub-id pub-id-type="pmid">26839363</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDavid</surname><given-names>A</given-names></name><name><surname>Finak</surname><given-names>G</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The contribution of cell cycle to heterogeneity in single-cell RNA-seq data</article-title><source>Nature Biotechnology</source><volume>34</volume><fpage>591</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.1038/nbt.3498</pub-id><pub-id pub-id-type="pmid">27281413</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinnis</surname><given-names>CS</given-names></name><name><surname>Murrow</surname><given-names>LM</given-names></name><name><surname>Gartner</surname><given-names>ZJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors</article-title><source>Cell Systems</source><volume>8</volume><fpage>329</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2019.03.003</pub-id><pub-id pub-id-type="pmid">30954475</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhl</surname><given-names>L</given-names></name><name><surname>Genové</surname><given-names>G</given-names></name><name><surname>Leptidis</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Mocci</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Buyandelger</surname><given-names>B</given-names></name><name><surname>Chivukula</surname><given-names>IV</given-names></name><name><surname>Segerstolpe</surname><given-names>Å</given-names></name><name><surname>Raschperger</surname><given-names>E</given-names></name><name><surname>Hansson</surname><given-names>EM</given-names></name><name><surname>Björkegren</surname><given-names>JLM</given-names></name><name><surname>Peng</surname><given-names>X-R</given-names></name><name><surname>Vanlandewijck</surname><given-names>M</given-names></name><name><surname>Lendahl</surname><given-names>U</given-names></name><name><surname>Betsholtz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>3953</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17740-1</pub-id><pub-id pub-id-type="pmid">32769974</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzumdar</surname><given-names>MD</given-names></name><name><surname>Tasic</surname><given-names>B</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A global double-fluorescent Cre reporter mouse</article-title><source>Genesis (New York, N.Y</source><volume>45</volume><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1002/dvg.20335</pub-id><pub-id pub-id-type="pmid">17868096</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>E</given-names></name><name><surname>Monovich</surname><given-names>A</given-names></name><name><surname>Tirosh-Finkel</surname><given-names>L</given-names></name><name><surname>Harrelson</surname><given-names>Z</given-names></name><name><surname>Rousso</surname><given-names>T</given-names></name><name><surname>Rinon</surname><given-names>A</given-names></name><name><surname>Harel</surname><given-names>I</given-names></name><name><surname>Evans</surname><given-names>SM</given-names></name><name><surname>Tzahor</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The contribution of Islet1-expressing splanchnic mesoderm cells to distinct branchiomeric muscles reveals significant heterogeneity in head muscle development</article-title><source>Development (Cambridge, England)</source><volume>135</volume><fpage>647</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1242/dev.007989</pub-id><pub-id pub-id-type="pmid">18184728</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noden</surname><given-names>DM</given-names></name><name><surname>Trainor</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Relations and interactions between cranial mesoderm and neural crest populations</article-title><source>Journal of Anatomy</source><volume>207</volume><fpage>575</fpage><lpage>601</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7580.2005.00473.x</pub-id><pub-id pub-id-type="pmid">16313393</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noden</surname><given-names>DM</given-names></name><name><surname>Epstein</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Embryonic origins of avian and mammalian laryngeal musculoskeletal structures</article-title><source>The FASEB Journal</source><volume>24</volume><elocation-id>172</elocation-id><pub-id pub-id-type="doi">10.1096/fasebj.24.1_supplement.172.1</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noizet</surname><given-names>M</given-names></name><name><surname>Lagoutte</surname><given-names>E</given-names></name><name><surname>Gratigny</surname><given-names>M</given-names></name><name><surname>Bouschbacher</surname><given-names>M</given-names></name><name><surname>Lazareth</surname><given-names>I</given-names></name><name><surname>Roest Crollius</surname><given-names>H</given-names></name><name><surname>Darzacq</surname><given-names>X</given-names></name><name><surname>Dugast-Darzacq</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Master regulators in primary skin fibroblast fate reprogramming in a human ex vivo model of chronic wounds</article-title><source>Wound Repair and Regeneration</source><volume>24</volume><fpage>247</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1111/wrr.12392</pub-id><pub-id pub-id-type="pmid">26663515</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>LE</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis</article-title><source>Developmental Cell</source><volume>16</volume><fpage>303</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2008.12.003</pub-id><pub-id pub-id-type="pmid">19217431</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prummel</surname><given-names>KD</given-names></name><name><surname>Nieuwenhuize</surname><given-names>S</given-names></name><name><surname>Mosimann</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The lateral plate mesoderm</article-title><source>Development (Cambridge, England)</source><volume>147</volume><elocation-id>dev175059</elocation-id><pub-id pub-id-type="doi">10.1242/dev.175059</pub-id><pub-id pub-id-type="pmid">32561665</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puré</surname><given-names>E</given-names></name><name><surname>Blomberg</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics</article-title><source>Oncogene</source><volume>37</volume><fpage>4343</fpage><lpage>4357</lpage><pub-id pub-id-type="doi">10.1038/s41388-018-0275-3</pub-id><pub-id pub-id-type="pmid">29720723</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Srivatsan</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Calderon</surname><given-names>D</given-names></name><name><surname>Noble</surname><given-names>WS</given-names></name><name><surname>Disteche</surname><given-names>CM</given-names></name><name><surname>Spielmann</surname><given-names>M</given-names></name><name><surname>Moens</surname><given-names>CB</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Systematic Reconstruction of the Cellular Trajectories of Mammalian Embryogenesis</article-title><source>Developmental Biology</source><volume>1</volume><elocation-id>447626</elocation-id><pub-id pub-id-type="doi">10.1101/2021.06.08.447626</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacchetti</surname><given-names>B</given-names></name><name><surname>Funari</surname><given-names>A</given-names></name><name><surname>Remoli</surname><given-names>C</given-names></name><name><surname>Giannicola</surname><given-names>G</given-names></name><name><surname>Kogler</surname><given-names>G</given-names></name><name><surname>Liedtke</surname><given-names>S</given-names></name><name><surname>Cossu</surname><given-names>G</given-names></name><name><surname>Serafini</surname><given-names>M</given-names></name><name><surname>Sampaolesi</surname><given-names>M</given-names></name><name><surname>Tagliafico</surname><given-names>E</given-names></name><name><surname>Tenedini</surname><given-names>E</given-names></name><name><surname>Saggio</surname><given-names>I</given-names></name><name><surname>Robey</surname><given-names>PG</given-names></name><name><surname>Riminucci</surname><given-names>M</given-names></name><name><surname>Bianco</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>No Identical “Mesenchymal Stem Cells” at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels</article-title><source>Stem Cell Reports</source><volume>6</volume><fpage>897</fpage><lpage>913</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2016.05.011</pub-id><pub-id pub-id-type="pmid">27304917</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saga</surname><given-names>Y</given-names></name><name><surname>Miyagawa-Tomita</surname><given-names>S</given-names></name><name><surname>Takagi</surname><given-names>A</given-names></name><name><surname>Kitajima</surname><given-names>S</given-names></name><name><surname>Miyazaki</surname><given-names>J i.</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube</article-title><source>Development (Cambridge, England)</source><volume>126</volume><fpage>3437</fpage><lpage>3447</lpage><pub-id pub-id-type="doi">10.1242/dev.126.15.3437</pub-id><pub-id pub-id-type="pmid">10393122</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sambasivan</surname><given-names>R</given-names></name><name><surname>Gayraud-Morel</surname><given-names>B</given-names></name><name><surname>Dumas</surname><given-names>G</given-names></name><name><surname>Cimper</surname><given-names>C</given-names></name><name><surname>Paisant</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Kelly</surname><given-names>R</given-names></name><name><surname>Tajbakhsh</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates</article-title><source>Developmental Cell</source><volume>16</volume><fpage>810</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.05.008</pub-id><pub-id pub-id-type="pmid">19531352</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebo</surname><given-names>ZL</given-names></name><name><surname>Jeffery</surname><given-names>E</given-names></name><name><surname>Holtrup</surname><given-names>B</given-names></name><name><surname>Rodeheffer</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A mesodermal fate map for adipose tissue</article-title><source>Development (Cambridge, England)</source><volume>145</volume><elocation-id>dev166801</elocation-id><pub-id pub-id-type="doi">10.1242/dev.166801</pub-id><pub-id pub-id-type="pmid">30045918</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sefton</surname><given-names>EM</given-names></name><name><surname>Kardon</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Connecting muscle development, birth defects, and evolution: An essential role for muscle connective tissue</article-title><source>Current Topics in Developmental Biology</source><volume>132</volume><fpage>137</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/bs.ctdb.2018.12.004</pub-id><pub-id pub-id-type="pmid">30797508</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>FOXP1 enhances fibrosis via activating Wnt/β-catenin signaling pathway in endometriosis</article-title><source>American Journal of Translational Research</source><volume>10</volume><fpage>3610</fpage><lpage>3618</lpage><pub-id pub-id-type="pmid">30662612</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spörle</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Epaxial-adaxial-hypaxial regionalisation of the vertebrate somite: evidence for a somitic organiser and a mirror-image duplication</article-title><source>Development Genes and Evolution</source><volume>211</volume><fpage>198</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1007/s004270100139</pub-id><pub-id pub-id-type="pmid">11455436</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuelsatz</surname><given-names>P</given-names></name><name><surname>Shearer</surname><given-names>A</given-names></name><name><surname>Yablonka-Reuveni</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ancestral Myf5 gene activity in periocular connective tissue identifies a subset of fibro/adipogenic progenitors but does not connote a myogenic origin</article-title><source>Developmental Biology</source><volume>385</volume><fpage>366</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2013.08.010</pub-id><pub-id pub-id-type="pmid">23969310</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swedlund</surname><given-names>B</given-names></name><name><surname>Lescroart</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cardiopharyngeal Progenitor Specification: Multiple Roads to the Heart and Head Muscles</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>12</volume><elocation-id>a036731</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a036731</pub-id><pub-id pub-id-type="pmid">31818856</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tajbakhsh</surname><given-names>S</given-names></name><name><surname>Rocancourt</surname><given-names>D</given-names></name><name><surname>Buckingham</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice</article-title><source>Nature</source><volume>384</volume><fpage>266</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1038/384266a0</pub-id><pub-id pub-id-type="pmid">8918877</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tallquist</surname><given-names>MD</given-names></name><name><surname>Weismann</surname><given-names>KE</given-names></name><name><surname>Hellstrom</surname><given-names>M</given-names></name><name><surname>Soriano</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Early myotome specification regulates PDGFA expression and axial skeleton development</article-title><source>Development</source><volume>127</volume><fpage>5059</fpage><lpage>5070</lpage><pub-id pub-id-type="doi">10.1242/dev.127.23.5059</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tapscott</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription</article-title><source>Development (Cambridge, England)</source><volume>132</volume><fpage>2685</fpage><lpage>2695</lpage><pub-id pub-id-type="doi">10.1242/dev.01874</pub-id><pub-id pub-id-type="pmid">15930108</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname><given-names>AH</given-names></name><name><surname>Ben-David</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The role of Fli-1 in normal cell function and malignant transformation</article-title><source>Oncogene</source><volume>19</volume><fpage>6482</fpage><lpage>6489</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1204042</pub-id><pub-id pub-id-type="pmid">11175364</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzahor</surname><given-names>E</given-names></name><name><surname>Kempf</surname><given-names>H</given-names></name><name><surname>Mootoosamy</surname><given-names>RC</given-names></name><name><surname>Poon</surname><given-names>AC</given-names></name><name><surname>Abzhanov</surname><given-names>A</given-names></name><name><surname>Tabin</surname><given-names>CJ</given-names></name><name><surname>Dietrich</surname><given-names>S</given-names></name><name><surname>Lassar</surname><given-names>AB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Antagonists of Wnt and BMP signaling promote the formation of vertebrate head muscle</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>3087</fpage><lpage>3099</lpage><pub-id pub-id-type="doi">10.1101/gad.1154103</pub-id><pub-id pub-id-type="pmid">14701876</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Moosdijk</surname><given-names>AAA</given-names></name><name><surname>van de Grift</surname><given-names>YBC</given-names></name><name><surname>de Man</surname><given-names>SMA</given-names></name><name><surname>Zeeman</surname><given-names>AL</given-names></name><name><surname>van Amerongen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A novel Axin2 knock-in mouse model for visualization and lineage tracing of WNT/CTNNB1 responsive cells</article-title><source>Genesis (New York, N.Y</source><volume>58</volume><elocation-id>e23387</elocation-id><pub-id pub-id-type="doi">10.1002/dvg.23387</pub-id><pub-id pub-id-type="pmid">32643876</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van de Sande</surname><given-names>B</given-names></name><name><surname>Flerin</surname><given-names>C</given-names></name><name><surname>Davie</surname><given-names>K</given-names></name><name><surname>De Waegeneer</surname><given-names>M</given-names></name><name><surname>Hulselmans</surname><given-names>G</given-names></name><name><surname>Aibar</surname><given-names>S</given-names></name><name><surname>Seurinck</surname><given-names>R</given-names></name><name><surname>Saelens</surname><given-names>W</given-names></name><name><surname>Cannoodt</surname><given-names>R</given-names></name><name><surname>Rouchon</surname><given-names>Q</given-names></name><name><surname>Verbeiren</surname><given-names>T</given-names></name><name><surname>De Maeyer</surname><given-names>D</given-names></name><name><surname>Reumers</surname><given-names>J</given-names></name><name><surname>Saeys</surname><given-names>Y</given-names></name><name><surname>Aerts</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A scalable SCENIC workflow for single-cell gene regulatory network analysis</article-title><source>Nature Protocols</source><volume>15</volume><fpage>2247</fpage><lpage>2276</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0336-2</pub-id><pub-id pub-id-type="pmid">32561888</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinagre</surname><given-names>T</given-names></name><name><surname>Moncaut</surname><given-names>N</given-names></name><name><surname>Carapuço</surname><given-names>M</given-names></name><name><surname>Nóvoa</surname><given-names>A</given-names></name><name><surname>Bom</surname><given-names>J</given-names></name><name><surname>Mallo</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Evidence for a myotomal Hox/Myf cascade governing nonautonomous control of rib specification within global vertebral domains</article-title><source>Developmental Cell</source><volume>18</volume><fpage>655</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2010.02.011</pub-id><pub-id pub-id-type="pmid">20412779</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Niu</surname><given-names>X</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Jullian</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Kelly</surname><given-names>RG</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name><name><surname>Christiaen</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A single-cell transcriptional roadmap for cardiopharyngeal fate diversification</article-title><source>Nature Cell Biology</source><volume>21</volume><fpage>674</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1038/s41556-019-0336-z</pub-id><pub-id pub-id-type="pmid">31160712</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Machon</surname><given-names>O</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The transcriptional regulator MEIS2 sets up the ground state for palatal osteogenesis in mice</article-title><source>The Journal of Biological Chemistry</source><volume>295</volume><fpage>5449</fpage><lpage>5460</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA120.012684</pub-id><pub-id pub-id-type="pmid">32169905</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitesell</surname><given-names>TR</given-names></name><name><surname>Chrystal</surname><given-names>PW</given-names></name><name><surname>Ryu</surname><given-names>JRR</given-names></name><name><surname>Munsie</surname><given-names>N</given-names></name><name><surname>Grosse</surname><given-names>A</given-names></name><name><surname>French</surname><given-names>CR</given-names></name><name><surname>Workentine</surname><given-names>ML</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>LJ</given-names></name><name><surname>Waskiewicz</surname><given-names>A</given-names></name><name><surname>Lehmann</surname><given-names>OJ</given-names></name><name><surname>Lawson</surname><given-names>ND</given-names></name><name><surname>Childs</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>foxc1 is required for embryonic head vascular smooth muscle differentiation in zebrafish</article-title><source>Developmental Biology</source><volume>453</volume><fpage>34</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2019.06.005</pub-id><pub-id pub-id-type="pmid">31199900</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>WM</given-names></name><name><surname>Otis</surname><given-names>C</given-names></name><name><surname>Etemad</surname><given-names>S</given-names></name><name><surname>Goldhamer</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Development and patterning of rib primordia are dependent on associated musculature</article-title><source>Developmental Biology</source><volume>468</volume><fpage>133</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2020.07.015</pub-id><pub-id pub-id-type="pmid">32768399</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>HV</given-names></name><name><surname>Tseng</surname><given-names>KC</given-names></name><name><surname>Flath</surname><given-names>M</given-names></name><name><surname>Fabian</surname><given-names>P</given-names></name><name><surname>Segil</surname><given-names>N</given-names></name><name><surname>Crump</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Foxc1 establishes enhancer accessibility for craniofacial cartilage differentiation</article-title><source>eLife</source><volume>10</volume><elocation-id>63595</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.63595</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto-Shiraishi</surname><given-names>Y</given-names></name><name><surname>Kuroiwa</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Wnt and BMP signaling cooperate with Hox in the control of Six2 expression in limb tendon precursor</article-title><source>Developmental Biology</source><volume>377</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2013.02.023</pub-id><pub-id pub-id-type="pmid">23499659</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacharias</surname><given-names>AL</given-names></name><name><surname>Lewandoski</surname><given-names>M</given-names></name><name><surname>Rudnicki</surname><given-names>MA</given-names></name><name><surname>Gage</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Pitx2 is an upstream activator of extraocular myogenesis and survival</article-title><source>Developmental Biology</source><volume>349</volume><fpage>395</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2010.10.028</pub-id><pub-id pub-id-type="pmid">21035439</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70235.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2021.05.26.445757" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2021.05.26.445757"/></front-stub><body><p>This study combines sophisticated lineage tracing and single-cell RNAseq analysis to provide insights into cell fate decision in myogenesis and fibrogenesis. The paper will be of interest to a broad audience of developmental biologists, as it provides evidence for a population of novel bipotent cells, which possess a signature of both muscle and connective tissue.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70235.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bronner</surname><given-names>Marianne E</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dxps055</institution-id><institution>California Institute of Technology</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Currie</surname><given-names>Peter</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02qa5kg76</institution-id><institution>Australian Regenerative Medicine Institute</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2021.05.26.445757">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2021.05.26.445757v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Identification of bipotent progenitors that give rise to myogenic and connective tissues in mouse&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Marianne Bronner as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Peter Currie (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>The reviewers found the paper interesting and potentially acceptable after revisions, including better descriptions of the scRNAseq by refining some of the in silico analyses and providing better quantitation. Currently, there is too much emphasis placed on possible signaling cross-talk which are not validated. While functional validation would be helpful, this seems like a minor aspect of the paper which could be reduced and toned down. The main contribution is the identification of myf5 positive progenitors able to contribute to the fibroblastic lineage. The full comments of the reviewers are provided below to help you in revising the paper.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Overall, this is a very interesting study and the conclusions of the paper are consistent with their presented data. The work will be of interest for the readership of <italic>eLife</italic>.</p><p>There are some concerns I have that require some additional clarification:</p><p>Overall, the description of the scRNAseq and the velocity analysis could be improved and for instance the criteria to decide whether a population is myo or fibrogenic should be better explained in the text.</p><p>In figure 1B, lung and foregut precursors are identified whereas the population was sorted based on Mesp1 previous expression which labels the mesoderm. Are these mesodermal components of the lung and foregut?</p><p>The myogenic nature of the cells could be better described and illustrated on figure 1 and 2 and the expression pattern of myf5 in the different clusters would help. It would also be helpful to show the expression pattern of PDGFRA on the UMAPs as this is a key gene in this study. The Myogenic gene set shown in Figure 1F does not include many myogenic genes (except maybe Tnnt1), could the authors comment on why this is?</p><p>In the working model of fate decision, the bipotent cells have a signature of Myf5+, Pdgfra- and Pdgfa+. However, there is no strong evidence showing that these cells are Pdgfra-. Is there any cell that transiently express both Myf5 and Pdgfra mRNA or protein? What's the transcriptional expression level of Pdgfra in the scRNAseq data of cells sorted from mo</p><p>use Myf5GFP-P/+ embryos at E12.5 and E14.5? Is it expressed in the non-myogenic cluster? Additionally, for the EOM subset of the Myf5 lineage at E11.5, the expression plot of Myf5 is not shown. Does the cell population in between the myogenic and non-myogenic cells have both Myf5 and Pdgfra expression?</p><p>For immunofluorescence experiments, quantification of the proportion of double positive cells would be important. Especially the results verifying that Myf5 cells partially compensate for the lack of neural crest (Figure 3F-I'), since the green cells are hard to distinguish from the figure and the Myf5-expressing cells indicated by yellow arrowheads also exist in Wnt1 lineage cells.</p><p>Direct examination of Pdgfra+ cells using immunostaining or RNAscope in Myf5+ and Myf5-null embryos may be needed to strengthen the conclusion in Figure 5. In addition, the asterisk labeled β-gal+ cells in Figure 5D show neither myogenic marker nor <italic>Sox9</italic> expression. The fate of these cells may merit discussion.</p><p>What is shown in figure 6 is not very clear. More specifically, the fibrogenic fraction at stages 12.5 and 14.5 could be better described. What are the hatched boxes represented on the figure? It looks like the fibroblastic fraction strongly decreases with age which goes against their claim that the bipotential population is maintained.</p><p>A quantification of the Myod-iCre double positive cells shown on figure S5 would be helpful</p><p>Do the authors mean that the stages gave a similar level of enrichment for the same GO terms and reactome pathways?</p><p>The number of embryos stained by immunohistochemistry for each condition is on the low side (n=2) and could be increased.</p><p>Figure legends are too succinct and lack important details</p><p>In Figure 3, the labels of A-E are not consistent with the schematic depiction showing the positions of transverse sections.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>A major strength of this manuscript is that it provides a comprehensive profiling of the embryonic craniofacial tissues in mouse, with the use of elaborated computational analysis, that will certainly be of great interest to the scientific community. The illustrations emanating from the in silico data are presented in an informative way, and the schemes are clear and elegant. It is also clearly written.</p><p>Specific point to address:</p><p>1. Some conclusions are solely based on the RNA-Seq data that would require further experimental validations. Specifically, based on Figure 4, the authors are claiming that two tyrosine kinase receptors, Bmpr1 and Ephb1 are among their top drivers genes of the myogenic EOM compartment, with two of their ligands expressed in the non-myogenic cells. To further test the relevance of an hypothetic paracrine signalling between these two Myf5 derived cell lineages, the authors could have undertaken a similar RNA in situ strategy (RNA-scope) as the one performed for Pdgfra and Pdgfa or IHC. A similar comment can be done with regards to figure 7, where the authors argue that Wnt/β-catenin pathway, emanating from the neural crest could influence the maintenance of the non-myogenic population. This hypothesis could be strengthen with downstream in situ validation experiments in the EOM region.</p><p>2. In figure 3, if I have understood correctly, it appears that the labels on the transversal sections depicted on the mouse embryo scheme are not reflecting those corresponding to the immunostaining tiles?</p><p>3. In figure 3 panel J, the authors are quantifying the number of double positive Tomato/GFP cells over the total GFP cells per region to determine the contribution of Myf5-lineage cells to the associated connective tissue in the EOM at E14.5. I have found it confusing that in order to create their graph, the authors are coming back to their transgenic line Myf5Cre/+;R26TdTom/+;PdgfraH2BGFP/+ without mentioning in the text, when they have previously used different lineage tracing strategy in the EOM at 13.5 (panel F to I).<italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>– Is it expected to obtain anterior somite cells in Mesp1+ lineage? Or even a lung/foregut population? Unexpected populations in Mesp1+ lineage are worth discussing already in the Results section, with respect to previous lineage tracing and clonal analyses, which also used the Mesp1 driver.</p><p>– P.4, L.111: &quot;indicated&quot; should read &quot;suggested&quot;, because RNA velocity is consistent with the clonal interpretation but cannot be treated as conclusive. Proper clonal analysis would be necessary.</p><p>– Figure 2 is potentially interesting, but requires validation to be conclusive, both regarding the existence of bipotent progenitors, and the transition from a myogenic to a connective state.</p><p>– Statement that &quot; Myf5-derived lineage contributes to connective tissue cells in the absence of neural crest&quot; suggest that experimental removal of NCCs would trigger cartilage formation from myogenic lineages even in the ventral regions. Could this be tested?</p><p>– Figure 4A,B shows again excessive reliance on RNA velocity for clonal inference.</p><p>– P.6, L.178L BMPRI are serine/threonine kinases, not tyrosine kinase. The conclusion relying solely on scRNA-seq data regarding signaling needs to be validated by complementary experiments. Many plots on Figure 4F are seemingly redundant and not informative.</p><p>– Figure 4: if the idea is to reconstruct the EOM trajectories, why not integrate the data from distinct time points?</p><p>– Figure 5: SCENIC analysis is presented rather superficially. For instance, what genomic sequences were used to search for putative binding motifs? Is accessibility data for EOM cells available?</p><p>– Some of the non-myogenic factors mentioned (Ebf1, Six2, Foxc1) have also been involved in muscle development in other systems, so this point deserves to be clarified.</p><p>– The Myf5 null mutant showing an increase in <italic>Sox9</italic>+ cells is consistent with the hypothetized fate choice, but should be contrasted with the presumed signaling cross-talk between cell populations: if the muscles are missing, how does this affect their connective partners?</p><p>– Conclusions based on colocalization would be better supported by quantitative data e.g. % of double positive cells measured from images, instead of qualitative image accompanied by statement like &quot;only rare double positive cells&quot;.</p><p>– It is not clear to this reviewer what the true value of Figures 6 and 7 are without further experimental validations. For instance, identification of candidate drivers for the non-myogenic fate calls for some degree of experimental validation of this prediction. the section on these TFs and on the Wnt pathway, inasmuch as they rely exclusively on computational analysis of descriptive scRNA-seq data, remain largely speculative.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.70235.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The reviewers found the paper interesting and potentially acceptable after revisions, including better descriptions of the scRNAseq by refining some of the in silico analyses and providing better quantitation. Currently, there is too much emphasis placed on possible signaling cross-talk which are not validated. While functional validation would be helpful, this seems like a minor aspect of the paper which could be reduced and toned down. The main contribution is the identification of myf5 positive progenitors able to contribute to the fibroblastic lineage. The full comments of the reviewers are provided below to help you in revising the paper.</p></disp-quote><p>We thank the Editor and Reviewers for assessing our work. We have added more explicit data on the scRNAseq, cell fate transition (Figure 4C) and markers used (Figure 1—figure supplement 3B, Figure 4—figure supplement 1D, Figure 6—figure supplement 1D and Figure 6—figure supplement 2C) to help better illustrate the myogenic and non-myogenic trajectories. We have also validated the signaling cross-talk directly by RNAscope (Figure 4E-H) and the expression of Foxp2 by immunostaining (Figure 7B-E). Assessment of the head, trunk and limb Myf5+ lineage potential to connective tissue was also performed by FACS (Figure 7F-G). In light of recently published work on the vascular potential of myogenic cells, we have added <italic>Scube1</italic> RNAscope analysis (Figure 5—figure supplement 1B-E). We have also consolidated our in-situ data with more replicates and quantifications (Figures 4H, 5J).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Overall, this is a very interesting study and the conclusions of the paper are consistent with their presented data. The work will be of interest for the readership of eLife.</p><p>There are some concerns I have that require some additional clarification:</p><p>Overall, the description of the scRNAseq and the velocity analysis could be improved and for instance the criteria to decide whether a population is myo or fibrogenic should be better explained in the text.</p></disp-quote><p>The myogenic and non-myogenic fractions were defined using Pdgf dichotomy and expression of selected markers. Expression patterns of these relevant myogenic and fibrogenic genes that helped to define the myogenic and non-myogenic clusters have been added as supplemental data (Figure 1—figure supplement 3B, Figure 4—figure supplement 1D, Figure 6—figure supplement 1D and Figure 6—figure supplement 2C).</p><disp-quote content-type="editor-comment"><p>In figure 1B, lung and foregut precursors are identified whereas the population was sorted based on Mesp1 previous expression which labels the mesoderm. Are these mesodermal components of the lung and foregut?</p></disp-quote><p>We thank the reviewer for pointing out this feature that needed explanation. Indeed, this is the case and the text was edited to clarify this point.</p><disp-quote content-type="editor-comment"><p>The myogenic nature of the cells could be better described and illustrated on figure 1 and 2 and the expression pattern of myf5 in the different clusters would help. It would also be helpful to show the expression pattern of PDGFRA on the UMAPs as this is a key gene in this study. The Myogenic gene set shown in Figure 1F does not include many myogenic genes (except maybe Tnnt1), could the authors comment on why this is?</p></disp-quote><p>Expression patterns of relevant myogenic and fibrogenic genes (including Pdfra) were added as supplemental data (Figure 1—figure supplement 3B, Figure 4—figure supplement 1D, Figure 6—figure supplement 1D and Figure 6—figure supplement 2C) to strengthen the points made. In addition, we find <italic>Msc, Des, Tcf21, Ttn, Myod</italic> and <italic>Myf5</italic> as top 7, 27, 28, 29, 38 and 61 gene, respectively. A possible explanation for typical myogenic genes appearing further down the list is their salt and pepper expression pattern and resolution of the scRNAseq at this stage.</p><disp-quote content-type="editor-comment"><p>In the working model of fate decision, the bipotent cells have a signature of Myf5+, Pdgfra- and Pdgfa+. However, there is no strong evidence showing that these cells are Pdgfra-. Is there any cell that transiently express both Myf5 and Pdgfra mRNA or protein? What's the transcriptional expression level of Pdgfra in the scRNAseq data of cells sorted from mouse Myf5GFP-P/+ embryos at E12.5 and E14.5? Is it expressed in the non-myogenic cluster? Additionally, for the EOM subset of the Myf5 lineage at E11.5, the expression plot of Myf5 is not shown. Does the cell population in between the myogenic and non-myogenic cells have both Myf5 and Pdgfra expression?</p></disp-quote><p>To specifically address the question of <italic>Myf5</italic> and <italic>Pdgfra</italic> co-expression, we added the expression patterns of <italic>Myf5</italic> and <italic>Pdgfra</italic> in all datasets in Figure 1—figure supplement 3B, Figure 4—figure supplement 1D, Figure 6—figure supplement 1D and Figure 6—figure supplement 2C. Myf5+ cells are overwhelmingly Pdgfra- in all datasets. Myf5+/Pdgfra+ cells represent 8% (E10.5), 5,5% (E11.5), 0,5% (E12.5) and 0,15% (E14.5) of all cells in each dataset. In terms of Pdgfra output, Pdgfra+ cells represent 40% (E10.5), 56% (E11.5), 3% (E12.5) and 7% (E14.5) in each dataset. Cells at the transition between the myogenic and non-myogenic fractions express low-levels of myogenic genes (including Myf5) and low levels of non-myogenic genes (including <italic>Pdgfra</italic>) as illustrated by Figure 4C (heatmap). This information was added to the text (Line 182) and to the legend of Figure 1—figure supplement 3B, Figure 4—figure supplement 1D, Figure 6—figure supplement 1D and Figure 6—figure supplement 2C. For immunofluorescence experiments, quantification of the proportion of double positive cells would be important. Especially the results verifying that Myf5 cells partially compensate for the lack of neural crest (Figure 3F-I'), since the green cells are hard to distinguish from the figure and the Myf5-expressing cells indicated by yellow arrowheads also exist in Wnt1 lineage cells.</p><p>We have not included histograms of quantifications since we were not able to detect any Wnt1-derived nlacZ+ cell in these immunostainings. All cells with recent Myf5 history at 13.5 were found in the Mesp1 lineage (100% versus 0% in Wnt1-derived). Regarding the busy nature of these immunostaining, we added red arrowhead to highlight the Wnt1-derived connective tissue, which is Myf5-. This is consistent with Myf5<sup>Cre/+</sup>;R26<sup>TdTom/+</sup>;Pdgfra<sup>H2BGFP/+</sup> counting at E14.5 in the EOM revealing higher Myf5-derived connective tissue in mesodermal domains, and Mesp1-driven scRNAseq which uncovered this population. However, future work could make use of Wnt1<sup>Cre/+</sup>;R26<sup>TdTom/+</sup>;Myf5<sup>GFP/+</sup> and Mesp1<sup>Cre/+</sup>;R26<sup>TdTom/+</sup>;Myf5<sup>GFP/+</sup> lines and FACS analyses at later stages to further exclude the possibility of Myf5+ cells deriving from neural crest, albeit neural crest generally accepted not to give rise to skeletal muscle.</p><disp-quote content-type="editor-comment"><p>Direct examination of Pdgfra+ cells using immunostaining or RNAscope in Myf5+ and Myf5-null embryos may be needed to strengthen the conclusion in Figure 5. In addition, the asterisk labeled β-gal+ cells in Figure 5D show neither myogenic marker nor Sox9 expression. The fate of these cells may merit discussion.</p></disp-quote><p>We have not investigated the fate of Myf5-derived cells in the absence of Myf5 beyond their integration in EOM cartilage primordium and <italic>Sox9</italic> expression. However, we reported previously that these cells can give rise to cartilage and dermis (Tajbakhsh 1996). Moreover, the identity of some Myf5-derived cells in the EOM in our study (those adjacent to the asterisk in Figure 5C) are indeed unknown. Given that they express neither <italic>Sox9</italic> nor myogenic markers, these cells might maintain an undifferentiated state at that stage (E12.5). It is also possible that Myf5 null cells are undergoing apoptosis as we reported previously (Sambasivan 2009). We added this point in the discussion.</p><disp-quote content-type="editor-comment"><p>What is shown in figure 6 is not very clear. More specifically, the fibrogenic fraction at stages 12.5 and 14.5 could be better described. What are the hatched boxes represented on the figure? It looks like the fibroblastic fraction strongly decreases with age which goes against their claim that the bipotential population is maintained.</p></disp-quote><p>The dotted boxes highlight the transitions to non-myogenic clusters in each dataset (Figure legend was updated). Indeed, the fibroblastic fraction is strongly reduced in the E12.5 and E14.5 datasets, which is expected, since they were generated using Myf5<sup>GFP</sup>, a recent history labeling strategy (compared to a cell lineage tracing with <italic>Myf5<sup>Cre</sup>:R26<sup>mTmG</sup></italic>). The myogenic and non-myogenic cells were still noted in these datasets and RNA velocity suggested that this transition still occurs at these stages. However, it is also expected that this potential subsides as muscle development proceeds, and the need of myogenic progenitors for mesenchymal support reduces. The text was revised to clarify that point.</p><disp-quote content-type="editor-comment"><p>A quantification of the Myod-iCre double positive cells shown on figure S5 would be helpful</p></disp-quote><p>Quantification of Myod<sup>iCre</sup> experiments has now been added and moved to Figure 5.</p><disp-quote content-type="editor-comment"><p>The sentence on line 229 and 230 is unclear. Do the authors mean that the stages gave a similar level of enrichment for the same GO terms and reactome pathways?</p></disp-quote><p>Yes, the number of genes underlying a given term is similar in all stages, as all stages contribute equally to a given term. The text was edited to clarify.</p><disp-quote content-type="editor-comment"><p>The number of embryos stained by immunohistochemistry for each condition is on the low side (n=2) and could be increased.</p></disp-quote><p>The n number was increased and quantifications were provided for RNA scope (n=3 for <italic>Ephr</italic>, <italic>Bmp</italic> and <italic>Pdgf</italic>, n=2 for <italic>Scube1</italic>), <italic>Myod</italic> lineage experiments (n=4), and <italic>Foxp2</italic> immunostainings (n=3).</p><disp-quote content-type="editor-comment"><p>Figure legends are too succinct and lack important details</p></disp-quote><p>Figure legends have been revised to include more information.</p><disp-quote content-type="editor-comment"><p>In Figure 3, the labels of A-E are not consistent with the schematic depiction showing the positions of transverse sections.</p></disp-quote><p>We thank the Reviewer for spotting this oversight which has now been corrected.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>A major strength of this manuscript is that it provides a comprehensive profiling of the embryonic craniofacial tissues in mouse, with the use of elaborated computational analysis, that will certainly be of great interest to the scientific community. The illustrations emanating from the in silico data are presented in an informative way, and the schemes are clear and elegant. It is also clearly written.</p><p>Specific point to address:</p><p>1. Some conclusions are solely based on the RNA-Seq data that would require further experimental validations. Specifically, based on Figure 4, the authors are claiming that two tyrosine kinase receptors, Bmpr1 and Ephb1 are among their top drivers genes of the myogenic EOM compartment, with two of their ligands expressed in the non-myogenic cells. To further test the relevance of an hypothetic paracrine signalling between these two Myf5 derived cell lineages, the authors could have undertaken a similar RNA in situ strategy (RNA-scope) as the one performed for Pdgfra and Pdgfa or IHC.</p></disp-quote><p>The signaling crosstalk inferred from the scRNAseq has now been validated by RNAscope and quantified (n=3 embryos). This data was added to Figure 4.</p><disp-quote content-type="editor-comment"><p>A similar comment can be done with regards to figure 7, where the authors argue that Wnt/β-catenin pathway, emanating from the neural crest could influence the maintenance of the non-myogenic population. This hypothesis could be strengthen with downstream in situ validation experiments in the EOM region.</p></disp-quote><p>This data has been moved to Figure 7—figure supplement 1E-H as it is more speculative as suggested by the Editor. Further comparative studies assessing NCC-derived and cranial mesoderm-derived signals could yield interesting results in regard to the orchestration of cranial muscle morphogenesis. This is however out of the scope of this study.</p><disp-quote content-type="editor-comment"><p>2. In figure 3, if I have understood correctly, it appears that the labels on the transversal sections depicted on the mouse embryo scheme are not reflecting those corresponding to the immunostaining tiles?</p></disp-quote><p>We thank the Reviewer for spotting this oversight which has now been corrected.</p><disp-quote content-type="editor-comment"><p>3. In figure 3 panel J, the authors are quantifying the number of double positive Tomato/GFP cells over the total GFP cells per region to determine the contribution of Myf5-lineage cells to the associated connective tissue in the EOM at E14.5. I have found it confusing that in order to create their graph, the authors are coming back to their transgenic line Myf5Cre/+;R26TdTom/+;PdgfraH2BGFP/+ without mentioning in the text, when they have previously used different lineage tracing strategy in the EOM at 13.5 (panel F to I).</p></disp-quote><p>We thank the Reviewer for spotting this oversight in displaying the data. This has now been clarified in the text to mention the mouse line being used.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>– Is it expected to obtain anterior somite cells in Mesp1+ lineage?</p></disp-quote><p>This point was demonstrated by Heude et al., and the text was edited to make it clearer to the readers.</p><disp-quote content-type="editor-comment"><p>Or even a lung/foregut population? Unexpected populations in Mesp1+ lineage are worth discussing already in the Results section, with respect to previous lineage tracing and clonal analyses, which also used the Mesp1 driver.</p></disp-quote><p>This issue was raised by another Reviewer and indeed it needed clarification in the text. The text was revised to include more information on Mesp1 derivatives.</p><disp-quote content-type="editor-comment"><p>– &quot;indicated&quot; should read &quot;suggested&quot;, because RNA velocity is consistent with the clonal interpretation but cannot be treated as conclusive. Proper clonal analysis would be necessary.</p></disp-quote><p>The text was edited accordingly.</p><disp-quote content-type="editor-comment"><p>– Figure 2 is potentially interesting, but requires validation to be conclusive, both regarding the existence of bipotent progenitors, and the transition from a myogenic to a connective state.</p><p>– Statement that &quot; Myf5-derived lineage contributes to connective tissue cells in the absence of neural crest&quot; suggest that experimental removal of NCCs would trigger cartilage formation from myogenic lineages even in the ventral regions. Could this be tested?</p></disp-quote><p>We agree with the Reviewer’s comment, however ablation of neural crest by diphtheria toxin induction for example (through a Wnt1 or Sox10 driver) would result in massive craniofacial defects, making any conclusion on the fate of myogenic cells challenging to interpret. While a more local disruption using regionalized Cre expression may be possible, we have not tried that approach as the combinatorial genetic strains are not available.</p><disp-quote content-type="editor-comment"><p>– Figure 4A,B shows again excessive reliance on RNA velocity for clonal inference.</p></disp-quote><p>We have added a coexpression score module to highlight the existence of a transition continuum between the 2 cell fates as was reported previously for neural crest fate transitions (Kameneva 2021).</p><disp-quote content-type="editor-comment"><p>– P.6, L.178L BMPRI are serine/threonine kinases, not tyrosine kinase. The conclusion relying solely on scRNA-seq data regarding signaling needs to be validated by complementary experiments. Many plots on Figure 4F are seemingly redundant and not informative.</p></disp-quote><p>We thank the Reviewer for spotting this oversight which has been corrected (and throughout the text). Unnecessary plots have been also removed.</p><disp-quote content-type="editor-comment"><p>– Figure 4: if the idea is to reconstruct the EOM trajectories, why not integrate the data from distinct time points?</p></disp-quote><p>We have tried to address this point, however merging the various EOM datasets appeared to be more challenging than previously anticipated. Therefore, we decided to keep them separated. New developments and approaches for batch effect corrections may yield better results in the future.</p><disp-quote content-type="editor-comment"><p>– Figure 5: SCENIC analysis is presented rather superficially. For instance, what genomic sequences were used to search for putative binding motifs? Is accessibility data for EOM cells available?</p></disp-quote><p>The genomic sequences and databases used have now been added to the Methods section. 2 cisTarget databases were used for SCENIC: “mm9-500bp-upstream-7species.mc9nr” (500bp upstream of TSS) and “mm9-tss-centered-10kb-7species.mc9nr” (10kb+/- TSS). The regulatory inferences are based on putative binding motifs and do not stem from EOM-specific interactions. However, they are curated based on coexpression in our EOM dataset. To our knowledge, accessibility data for the EOM specifically is not available.</p><disp-quote content-type="editor-comment"><p>– Some of the non-myogenic factors mentioned (Ebf1, Six2, Foxc1) have also been involved in muscle development in other systems, so this point deserves to be clarified.</p></disp-quote><p>We thank the Reviewer for this comment. A section has now been added to the discussion to discuss the Fox transcription factor family.</p><disp-quote content-type="editor-comment"><p>– The Myf5 null mutant showing an increase in Sox9+ cells is consistent with the hypothetized fate choice, but should be contrasted with the presumed signaling cross-talk between cell populations: if the muscles are missing, how does this affect their connective partners?</p></disp-quote><p>This is an interesting point we have not addressed. However, disruption of <italic>Myf5</italic> seems to have a strong effect on the commitment of a portion of the <italic>Myf5</italic>-derived cells to the cartilage lineage. The remaining cells (adjacent to the asterisk in Figure 5C), which do not express <italic>Sox9</italic> or myogenic factors, may be undergoing apoptosis as we described previously for the <italic>Myf5</italic> null (Sambasivan 2009).</p><disp-quote content-type="editor-comment"><p>– Conclusions based on colocalization would be better supported by quantitative data e.g. % of double positive cells measured from images, instead of qualitative image accompanied by statement like &quot;only rare double positive cells&quot;.</p></disp-quote><p>Quantification of the Myod<sup>iCre</sup> experiments have now been added to Figure 5 (n=4).</p><disp-quote content-type="editor-comment"><p>– It is not clear to this reviewer what the true value of Figures 6 and 7 are without further experimental validations. For instance, identification of candidate drivers for the non-myogenic fate calls for some degree of experimental validation of this prediction. the section on these TFs and on the Wnt pathway, inasmuch as they rely exclusively on computational analysis of descriptive scRNA-seq data, remain largely speculative.</p></disp-quote><p>Foxp2 expression has now been validated by immunostaining and quantified (Figure 7). The involvement of Wnt/Bcat activity was move to Figure 7—figure supplement 1E-H as it is more speculativ</p></body></sub-article></article>